Claus Belka
#130,276
Most Influential Person Now
Researcher
Claus Belka's AcademicInfluence.com Rankings
Claus Belkacomputer-science Degrees
Computer Science
#5696
World Rank
#6014
Historical Rank
Machine Learning
#1606
World Rank
#1628
Historical Rank
Artificial Intelligence
#1841
World Rank
#1873
Historical Rank
Database
#2837
World Rank
#2962
Historical Rank
Download Badge
Computer Science
Claus Belka's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Claus Belka Influential?
(Suggest an Edit or Addition)Claus Belka's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal (2003) (890)
- A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck (2006) (277)
- Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis (2000) (264)
- Radiation induced CNS toxicity – molecular and cellular mechanisms (2001) (262)
- Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE). (2015) (259)
- ESTRO-ACROP guideline "target delineation of glioblastomas". (2016) (252)
- Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches (2019) (207)
- Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial (2018) (192)
- MR-guidance in clinical reality: current treatment challenges and future perspectives (2019) (191)
- Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids. (1999) (186)
- Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. (2001) (179)
- CD8+ tumour‐infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK‐ROG) (2016) (172)
- Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement (2020) (165)
- Dying cell clearance and its impact on the outcome of tumor radiotherapy (2012) (155)
- Guardians of cell death: the Bcl-2 family proteins. (2003) (152)
- A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling (2017) (149)
- Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. (2016) (140)
- Current concepts in clinical radiation oncology (2013) (138)
- Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis (2000) (137)
- Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL (2001) (133)
- Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences (2017) (130)
- Therapeutic options for recurrent malignant glioma. (2011) (129)
- Apoptosis-modulating agents in combination with radiotherapy-current status and outlook. (2004) (129)
- HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2014) (129)
- Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. (2005) (128)
- Counting colonies of clonogenic assays by using densitometric software (2007) (124)
- [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning (2009) (122)
- FET-PET for malignant glioma treatment planning. (2011) (122)
- Investigating CT to CBCT image registration for head and neck proton therapy as a tool for daily dose recalculation. (2015) (117)
- Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients (2015) (114)
- Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo (2006) (111)
- Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis. (2001) (108)
- Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology (2002) (106)
- Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG (2016) (105)
- Deep venous thrombosis and pulmonary artery embolism in high‐grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance (1995) (104)
- Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial. (2019) (102)
- Irradiation and bevacizumab in high-grade glioma retreatment settings. (2012) (102)
- Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial. (2017) (102)
- Lipopolysaccharide Activates Caspase-1 (Interleukin-1–Converting Enzyme) in Cultured Monocytic and Endothelial Cells (1998) (101)
- HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2016) (100)
- The tyrosine kinase Lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation (1999) (98)
- Impact of localized radiotherapy on blood immune cells counts and function in humans. (1999) (98)
- Type I and type II reactions in TRAIL-induced apoptosis – results from dose–response studies (2005) (97)
- Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients (2013) (94)
- Iodine-125 brachytherapy for brain tumours - a review (2012) (94)
- Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis (2005) (93)
- Radiation-induced apoptosis in human lymphocytes and lymphoma cells critically relies on the up-regulation of CD95/Fas/APO-1 ligand. (1998) (93)
- Tumor necrosis factor (TNF)‐alpha activates c‐raf‐1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. (1995) (92)
- MicroRNA expression profiles in human cancer cells after ionizing radiation (2011) (92)
- External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis (2017) (88)
- Inhibition of Jurkat-T-lymphocyte Na+/H+-exchanger by CD95(Fas/Apo-1)-receptor stimulation (2000) (88)
- Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway (2004) (87)
- The PD‐1/PD‐L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG) (2017) (87)
- Celecoxib activates a novel mitochondrial apoptosis signaling pathway (2003) (86)
- Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets (2014) (86)
- Comparison of proton therapy treatment planning for head tumors with a pencil beam algorithm on dual and single energy CT images. (2016) (83)
- Treatment planning and evaluation of gated radiotherapy in left-sided breast cancer patients using the CatalystTM/SentinelTM system for deep inspiration breath-hold (DIBH) (2016) (82)
- Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway (2010) (81)
- Distribution of prostate sentinel nodes: a SPECT-derived anatomic atlas. (2007) (81)
- ScatterNet: A convolutional neural network for cone‐beam CT intensity correction (2018) (78)
- Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells. (1998) (78)
- Survival of tumor cells after proton irradiation with ultra-high dose rates (2011) (77)
- Comparing cone-beam CT intensity correction methods for dose recalculation in adaptive intensity-modulated photon and proton therapy for head and neck cancer (2015) (76)
- TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma (2017) (75)
- Tumour Hypoxia: Impact on Biology, Prognosis and Treatment of Solid Malignant Tumours (2004) (75)
- Investigating deformable image registration and scatter correction for CBCT-based dose calculation in adaptive IMPT. (2016) (74)
- Intra-fraction motion of the prostate is a random walk (2015) (73)
- Current status and perspectives of interventional clinical trials for glioblastoma – analysis of ClinicalTrials.gov (2017) (71)
- Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma (2010) (70)
- New insights in the role of Bcl-2 Bcl-2 and the endoplasmic reticulum (2002) (69)
- Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondrial apoptotic pathways (2004) (69)
- Hypofractionated reirradiation for recurrent malignant glioma (2009) (69)
- Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review (2020) (68)
- Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway (2006) (68)
- TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway (2005) (67)
- Evidence-based radiation oncology: oesophagus. (2009) (64)
- Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells (2018) (64)
- Molecular ordering of hypoxia-induced apoptosis: critical involvement of the mitochondrial death pathway in a FADD/caspase-8 independent manner (2004) (63)
- Cooperative Cytotoxicity of Proteasome Inhibitors and Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand in Chemoresistant Bcl-2-Overexpressing Cells (2005) (62)
- Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation. (2016) (62)
- Intracellular mediators of erucylphosphocholine-induced apoptosis (2003) (61)
- Evaluation of daily patient positioning for radiotherapy with a commercial 3D surface-imaging system (Catalyst™) (2016) (61)
- Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids (2013) (61)
- Radiotherapy and "new" drugs-new side effects? (2011) (61)
- Celecoxib activates a novel mitochondrial apoptosis signaling pathway. (2003) (60)
- Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option (2014) (60)
- MiRNA expression patterns predict survival in glioblastoma (2011) (60)
- Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis. (1998) (59)
- Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model (2009) (59)
- Outcome After PSMA PET/CT–Based Salvage Radiotherapy in Patients with Biochemical Recurrence After Radical Prostatectomy: A 2-Institution Retrospective Analysis (2018) (58)
- CBCT correction using a cycle-consistent generative adversarial network and unpaired training to enable photon and proton dose calculation (2019) (58)
- Ligand Bound β1 Integrins Inhibit Procaspase-8 for Mediating Cell Adhesion-Mediated Drug and Radiation Resistance in Human Leukemia Cells (2007) (58)
- First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients (2020) (56)
- Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases (2019) (56)
- Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity. (2015) (56)
- Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy (2018) (55)
- Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways. (2010) (55)
- The role of PDGF in radiation oncology (2007) (54)
- Existential behavioural therapy for informal caregivers of palliative patients: a randomised controlled trial (2013) (54)
- Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease (2017) (54)
- Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy. (2018) (53)
- Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. (2010) (53)
- The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation (2010) (53)
- The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro (2006) (53)
- Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement (2020) (52)
- Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide (2010) (52)
- Why "Radiation Oncology" (2006) (52)
- Characteristics of gated treatment using an optical surface imaging and gating system on an Elekta linac (2015) (50)
- First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments (2020) (50)
- A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection (2018) (49)
- Recent advances of PET imaging in clinical radiation oncology (2020) (49)
- Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images (2016) (49)
- Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent ‘type I' mode (2013) (48)
- Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8-independent manner by activation of the mitochondrial cell death pathway (2004) (48)
- Adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard? (2008) (48)
- Radiation sensitivity and apoptosis in human lymphoma cells (2001) (48)
- Correction to: Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease—Effects of modern radiotherapy techniques (2017) (48)
- Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer--results from a Phase I trial. (1997) (48)
- Choline PET based dose-painting in prostate cancer - Modelling of dose effects (2010) (47)
- CT-guided percutaneous drainage of intra-abdominal abscesses: APACHE III score stratification of 1-year results (2002) (47)
- FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status. (2012) (47)
- European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. (2022) (46)
- Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique. (2007) (46)
- Comparing Unet training with three different datasets to correct CBCT images for prostate radiotherapy dose calculations (2019) (46)
- Phantom based evaluation of CT to CBCT image registration for proton therapy dose recalculation (2015) (45)
- Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG) (2017) (45)
- Risk of Second Malignancies after Prostate Irradiation? (2007) (45)
- Progressive resistance training in cachectic head and neck cancer patients undergoing radiotherapy: a randomized controlled pilot feasibility trial (2018) (45)
- Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results. (2018) (44)
- Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial. (2005) (44)
- Identification of urinary modified nucleosides and ribosylated metabolites in humans via combined ESI-FTICR MS and ESI-IT MS analysis (2008) (43)
- Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis. (2010) (43)
- Hypofractionated radiotherapy for prostate cancer (2014) (42)
- Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1–3 cerebral metastases (2014) (42)
- Current status and recent advances in reirradiation of glioblastoma (2021) (42)
- Apoptotic Response of Chang Cells to Infection with Pseudomonas aeruginosa Strains PAK and PAO-I: Molecular Ordering of the Apoptosis Signaling Cascade and Role of Type IV Pili (2003) (41)
- Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study (2018) (41)
- [18F]Fluoroethyltyrosine–Positron Emission Tomography-Based Therapy Monitoring after Stereotactic Iodine-125 Brachytherapy in Patients with Recurrent High-Grade Glioma (2013) (40)
- Irradiation-induced pneumonitis mediated by the CD95/CD95-ligand system. (2006) (40)
- Feasibility of MR-only proton dose calculations for prostate cancer radiotherapy using a commercial pseudo-CT generation method (2017) (40)
- Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer. (2007) (40)
- Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. (2006) (40)
- Curative treatment of oesophageal carcinoma: current options and future developments (2011) (39)
- Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy (2018) (39)
- A 4-miRNA signature predicts the therapeutic outcome of glioblastoma (2016) (39)
- Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group. (2019) (39)
- The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways (2003) (39)
- Impact of 68Ga-PSMA PET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective Analysis (2018) (39)
- Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide (1999) (38)
- Integrin-linked kinase interacts with caspase-9 and -8 in an adhesion-dependent manner for promoting radiation-induced apoptosis in human leukemia cells (2007) (38)
- Novel chemotherapeutic agents for the treatment of glioblastoma multiforme (2003) (38)
- Real-time intra-fraction motion management in breast cancer radiotherapy: analysis of 2028 treatment sessions (2018) (38)
- Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT (2013) (37)
- PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives (2018) (37)
- HSP90 inhibition as a means of radiosensitizing resistant, aggressive soft tissue sarcomas. (2015) (37)
- Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated γ-irradiation (2014) (37)
- Apoptosis induction and tumor cell repopulation: The yin and yang of radiotherapy (2011) (37)
- Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy (2017) (36)
- Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET–PET (2012) (35)
- Interleukin-1-induced intracellular signaling pathways converge in the activation of mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 and the subsequent phosphorylation of the 27-kilodalton heat shock protein in monocytic cells. (1994) (35)
- Influence of hypoxia on TRAIL-induced apoptosis in tumor cells. (2004) (35)
- TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study (2019) (35)
- Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-nonmethylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial. (2013) (34)
- On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model (2016) (33)
- Array-based comparative gene expression analysis of tumor cells with increased apoptosis resistance after hypoxic selection (2005) (33)
- Reirradiation with Alternating Docetaxel-Based Chemotherapy for Recurrent Head and Neck Squamous Cell Carcinoma (2010) (33)
- Immunological aspects of radiotherapy (2014) (33)
- Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition (2005) (33)
- Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance? (2015) (33)
- Severe skin reaction secondary to concomitant radiotherapy plus cetuximab (2008) (33)
- Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis (2017) (33)
- Comparison and limitations of DVH-based NTCP models derived from 3D-CRT and IMRT data for prediction of gastrointestinal toxicities in prostate cancer patients by using propensity score matched pair analysis. (2015) (33)
- Single isocenter stereotactic radiosurgery for patients with multiple brain metastases: dosimetric comparison of VMAT and a dedicated DCAT planning tool (2019) (32)
- Evaluation of proton and photon dose distributions recalculated on 2D and 3D Unet-generated pseudoCTs from T1-weighted MR head scans (2019) (32)
- Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation. (2019) (32)
- Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of protein kinase B/Akt-mediated survival-signaling. (2006) (32)
- Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis. (2018) (32)
- Adjuvant radiotherapy after breast conserving surgery - a comparative effectiveness research study. (2015) (31)
- Mitomycin C in combination with radiotherapy as a potent inhibitor of tumour cell repopulation in a human squamous cell carcinoma (2002) (31)
- Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer – a phase I study (2006) (31)
- Serum-Derived Plasminogen Is Activated by Apoptotic Cells and Promotes Their Phagocytic Clearance (2012) (30)
- Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs. (2004) (30)
- Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck (2015) (30)
- Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic 18F-FMISO PET for Head and Neck Cancer Radiotherapy (2019) (30)
- Hippocampus sparing in whole-brain radiotherapy (2014) (30)
- Molecular requirements for the combined effects of TRAIL and ionising radiation. (2003) (30)
- Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients (2014) (30)
- Quantification of the uncertainties of a biological model and their impact on variable RBE proton treatment plan optimization. (2017) (30)
- Optical Surface Scanning for Patient Positioning in Radiation Therapy: A Prospective Analysis of 1902 Fractions (2018) (29)
- Definitive radiotherapy and Single-Agent radiosensitizing Ifosfamide in Patients with localized, irresectable Soft Tissue Sarcoma: A retrospective analysis (2010) (29)
- 70 Gy or more: which dose for which prostate cancer? (2005) (29)
- Radiotherapy with and without temozolomide in elderly patients with glioblastoma (2012) (28)
- Dosimetric accuracy and radiobiological implications of ion computed tomography for proton therapy treatment planning (2019) (28)
- A comparative assessment of prostate positioning guided by three-dimensional ultrasound and cone beam CT (2015) (28)
- Re‐irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK) (2018) (27)
- Validation of the prognostic Heidelberg re-irradiation score in an independent mono-institutional patient cohort (2014) (27)
- High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma (2018) (27)
- MEK1 and Erk1/2 kinases as targets for the modulation of radiation responses. (2000) (27)
- First Experiences of Radiation Treatment Planning with PET/CT (2006) (26)
- Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are time- and dose-dependent (2012) (26)
- Decomposing a prior-CT-based cone-beam CT projection correction algorithm into scatter and beam hardening components (2017) (26)
- Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2 (2018) (26)
- Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma (2016) (26)
- A normal tissue dose response model of dynamic repair processes (2006) (26)
- Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease (2018) (25)
- Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. (2008) (24)
- Dihydroartemisinin is a Hypoxia-Active Anti-Cancer Drug in Colorectal Carcinoma Cells (2014) (24)
- Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients (2021) (24)
- Total-Body Irradiation—Role and Indications (2006) (24)
- Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes (2018) (24)
- Pre‐clinical heterotopic intrathoracic heart xenotransplantation: a possibly useful clinical technique (2015) (24)
- Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments. (2020) (24)
- Radiotherapy of oligometastatic prostate cancer: a systematic review (2021) (24)
- Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy (2020) (24)
- Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer (2017) (24)
- Interleukin (IL)-6 signaling leads to phosphorylation of the small heat shock protein (Hsp)27 through activation of the MAP kinase and MAPKAP kinase 2 pathway in monocytes and monocytic leukemia cells. (1995) (24)
- Synthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway (2011) (23)
- Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy (2020) (23)
- Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real‐life Limited‐disease Small‐cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging (2017) (23)
- 2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma (2020) (23)
- Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model. (2019) (23)
- Hypoxia downregulates Ku70/80 expression in cervical carcinoma tumors. (2008) (23)
- SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy. (2017) (22)
- Outcome in unresectable glioblastoma: MGMT promoter methylation makes the difference (2016) (22)
- Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma. (2019) (22)
- Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis (2020) (22)
- Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance. (2017) (22)
- Analysis of complex protein kinase B signalling pathways in human prostate cancer samples (2008) (22)
- Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-RT regimen in unresectable locally advanced NSCLC: The ETOP NICOLAS phase II trial. (2018) (22)
- ESTRO ACROP guidelines for target volume definition in pancreatic cancer. (2020) (22)
- Long-Term Outcome of Mitomycin C- and 5-FU-Based Primary Radiochemotherapy for Esophageal Cancer (2010) (22)
- Surgery vs. radiotherapy in localized prostate cancer. Which is best? (2008) (22)
- Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer” (2020) (22)
- Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck – clinical results from the cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer” (2018) (22)
- Shorter treatment times reduce the impact of intra-fractional motion (2018) (21)
- Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis (2018) (21)
- Ionizing radiation and the activation of caspase-8 in highly apoptosis-sensitive lymphoma cells. (1999) (21)
- A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer (2016) (21)
- Death receptor ligands: new strategies for combined treatment with ionizing radiation. (2003) (21)
- Factors associated with the decline of psychological support in hospitalized patients with cancer (2019) (21)
- A prospective study on neurocognitive effects after primary radiotherapy in high-grade glioma patients (2015) (21)
- Comparison of prostate positioning guided by three-dimensional transperineal ultrasound and cone beam CT (2016) (21)
- Feasibility and Early Clinical Experience of Online Adaptive MR-Guided Radiotherapy of Liver Tumors (2021) (21)
- Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas (2015) (20)
- Timing of radiotherapy following breast-conserving surgery: outcome of 1393 patients at a single institution (2014) (20)
- Technical evaluation of different respiratory monitoring systems used for 4D CT acquisition under free breathing (2015) (20)
- Novel rotatable tabletop for total-body irradiation using a linac-based VMAT technique (2019) (20)
- Radiotherapy and TRAIL for cancer therapy. (2013) (20)
- Analysis of clonogenic growth in vitro (2021) (20)
- Toxicity and outcome of pelvic IMRT for node-positive prostate cancer (2012) (20)
- Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre (2012) (19)
- A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy‐treated head and neck squamous cell carcinoma (HNSCC) (2018) (19)
- Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold (2018) (19)
- Towards a novel small animal proton irradiation platform: the SIRMIO project (2019) (19)
- ESTRO ACROP guideline for target volume delineation of skull base tumors. (2020) (19)
- Neoadjuvant radiotherapy followed by mastectomy and immediate breast reconstruction (2017) (19)
- A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy (2019) (19)
- Margin reduction in radiotherapy for glioblastoma through 18F-fluoroethyltyrosine PET? - A recurrence pattern analysis. (2020) (18)
- Application of fluence field modulation to proton computed tomography for proton therapy imaging (2017) (18)
- Visualization, imaging and new preclinical diagnostics in radiation oncology (2014) (18)
- The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence (2015) (18)
- Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors (2013) (18)
- Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy (2020) (18)
- Analysis of equivalent uniform dose (EUD) and conventional radiation treatment parameters after primary and re-irradiation of malignant glioma (2013) (18)
- Combined action of celecoxib and ionizing radiation in prostate cancer cells is independent of pro-apoptotic Bax. (2009) (18)
- ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology. (2021) (18)
- Palliative percutaneous radiotherapy in non-small-cell lung cancer. (2004) (17)
- Stability and reproducibility of 6013 deep inspiration breath-holds in left-sided breast cancer (2020) (17)
- Detection of Cerebrospinal Fluid Dissemination of Recurrent Glioblastoma Using TSPO-PET With 18F-GE-180. (2018) (17)
- Impact of MLC properties and IMRT technique in meningioma and head-and-neck treatments (2015) (17)
- Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas (2018) (17)
- Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions (2009) (17)
- Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid) (2015) (17)
- State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours-a German radiation oncology survey. (2019) (17)
- Disruption of cell death signaling in cancer: impact on disease prognosis and response to therapy. (2003) (17)
- Efficacy of a Triple Treatment with Irradiation, Agonistic TRAIL Receptor Antibodies and EGFR Blockade (2009) (17)
- The fate of irradiated tumor cells (2006) (17)
- RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial (2020) (17)
- Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC. (2017) (17)
- Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks (2020) (16)
- SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy (2017) (16)
- Post-processing sets of tilted CT volumes as a method for metal artifact reduction (2014) (16)
- PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions (2021) (16)
- Radiation treatment parameters for re-irradiation of malignant glioma (2012) (16)
- Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter study. (2015) (16)
- Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patients (2015) (16)
- Temozolomide during radiotherapy of glioblastoma multiforme (2017) (16)
- 18F-FET PET prior to recurrent high-grade glioma re-irradiation—additional prognostic value of dynamic time-to-peak analysis and early static summation images? (2017) (16)
- Pharmacokinetics and biodistribution of Erufosine in nude mice - implications for combination with radiotherapy (2009) (15)
- A novel approach to EPID-based 3D volumetric dosimetry for IMRT and VMAT QA (2018) (15)
- Feasibility of 4DCBCT-based proton dose calculation: An ex vivo porcine lung phantom study. (2019) (15)
- Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases (2018) (15)
- Prefraction displacement and intrafraction drift of the prostate due to perineal ultrasound probe pressure (2017) (15)
- Tributyltin (TBT) induces ultra-rapid caspase activation independent of apoptosome formation in human platelets (2003) (15)
- Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment (2011) (15)
- Feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion (2016) (15)
- Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair (2016) (15)
- Impact of Radiotherapy, Chemotherapy and Surgery in Multimodal Treatment of Locally Advanced Esophageal Cancer (2012) (15)
- The random walk model of intrafraction movement (2013) (15)
- Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions. (2009) (15)
- The role of tyrosine kinases and their substrates in signal transmission of hematopoietic growth factors: a short review. (1995) (15)
- Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study (2020) (15)
- Reduction of cardiac and coronary artery doses in irradiation of left-sided breast cancer during inspiration breath hold (2016) (14)
- Wound monitoring of pH and oxygen in patients after radiation therapy (2019) (14)
- Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting (2021) (14)
- Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy. (2019) (14)
- Importance of Bak for celecoxib-induced apoptosis. (2008) (14)
- Total-body irradiation--role and indications: results from the German Registry for Stem Cell Transplantation (DRST). (2006) (14)
- Recent Developments in Radiation Oncology: An Overview of Individualised Treatment Strategies in Breast Cancer (2018) (14)
- Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients (2021) (14)
- Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy (2016) (13)
- Age-dependent differences in DNA damage after in vitro CT exposure (2018) (13)
- Toward a new treatment planning approach accounting for in vivo proton range verification (2018) (13)
- Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer (2021) (13)
- Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment (2019) (13)
- 13LBA Improved overall survival by adding regional hyperthermia to neo-adjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): Long-term outcomes of the EORTC 62961/ESHO randomized phase III study (2015) (13)
- Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC (2020) (13)
- Three-dimensional surface imaging in breast cancer: a new tool for clinical studies? (2020) (13)
- Corrigendum: Comparing Unet training with three different datasets to correct CBCT images for prostate radiotherapy dose calculations (2019 Phys. Med. Biol. 64 035011) (2019) (13)
- Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment (2016) (13)
- Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy (2021) (13)
- Bcl-2 mediated inhibition of erucylphosphocholine-induced apoptosis depends on its subcellular localisation. (2005) (13)
- Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer (2021) (13)
- Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy (2020) (12)
- Clinical impact of predictive assays for acute and late radiation morbidity. (1998) (12)
- Distant metastasis time to event analysis with CNNs in independent head and neck cancer cohorts (2021) (12)
- Trends in use and outcome of postoperative radiotherapy following mastectomy: A population-based study. (2017) (12)
- Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis (2019) (12)
- Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck (2013) (12)
- CT-guided percutaneous drainage of intra-abdominal abscesses: APACHE III score stratification of 1-year results. Acute Physiology, Age, Chronic Health Evaluation. (2002) (12)
- Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolomide in newly diagnosed, MGMT-non-methylated glioblastoma patients. (2014) (12)
- Current status and recent advances in resection cavity irradiation of brain metastases (2021) (12)
- Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer (2020) (12)
- Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma (2021) (12)
- Real-time 4D-MRI-based internal target volume definition for moving lung tumors. (2020) (12)
- Radiotherapy of spinal cord gliomas (2015) (11)
- Patient positioning and immobilization procedures for hybrid MR-Linac systems (2021) (11)
- Multi-criterial patient positioning based on dose recalculation on scatter-corrected CBCT images. (2017) (11)
- Treatment-outcome for synchronous head-and-neck and oesophageal squamous cell carcinoma. (2005) (11)
- Technical Note: Millimeter precision in ultrasound based patient positioning: experimental quantification of inherent technical limitations. (2014) (11)
- Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy (2021) (11)
- Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma (2020) (11)
- Technical Issues of [18F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients – A Review (2012) (11)
- How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience (2018) (11)
- Hippocampal sparing radiotherapy for glioblastoma patients: a planning study using volumetric modulated arc therapy (2016) (11)
- Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma (2018) (10)
- The additional loss of Bak and not the lack of the protein tyrosine kinase p56/Lck in one JCaM1.6 subclone caused pronounced apoptosis resistance in response to stimuli of the intrinsic pathway (2009) (10)
- Application of single- and dual-energy CT brain tissue segmentation to PET monitoring of proton therapy (2017) (10)
- Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis (2019) (10)
- Impact of surface-guided positioning on the use of portal imaging and initial set-up duration in breast cancer patients (2019) (10)
- Isobologram analysis of triple therapies (2006) (10)
- Stereoscopic X-ray imaging, cone beam CT, and couch positioning in stereotactic radiotherapy of intracranial tumors: preliminary results from a cross-modality pilot installation (2016) (10)
- Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial (2018) (10)
- Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival (2012) (10)
- Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate (2022) (10)
- Spatial Resolution Enhancement in Integration-Mode Detectors for Proton Radiography and Tomography (2016) (10)
- Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy. (2019) (10)
- Mitomycin C-related hemolytic uremic syndrome in cancer patients. (1998) (10)
- Hippocampal EUD in primarily irradiated glioblastoma patients (2014) (10)
- SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine (2020) (10)
- Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma (2018) (10)
- [Death inducing ligands in combination with ionizing radiation: objective and current knowledge]. (2003) (10)
- Comparison of planned dose on different CT image sets to four-dimensional Monte Carlo dose recalculation using the patient's actual breathing trace for lung stereotactic body radiation therapy. (2019) (9)
- Multifocal high-grade glioma radiotherapy safety and efficacy (2021) (9)
- Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma (2021) (9)
- Dose-guided patient positioning in proton radiotherapy using multicriteria-optimization. (2019) (9)
- Simultaneous stereotactic radiosurgery of multiple brain metastases using single-isocenter dynamic conformal arc therapy: a prospective monocentric registry trial (2020) (9)
- The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy (2020) (9)
- Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond (2021) (9)
- Iodine-125 brachytherapy as upfront and salvage treatment for brain metastases (2016) (9)
- Routine use of Monte Carlo dose computation for head and neck IMRT optimization (2003) (9)
- Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck (2021) (8)
- Paclitaxel in simultaneous radiochemotherapy of head and neck cancer: preclinical and clinical results. (1997) (8)
- Hypofractionated Radiotherapy for Anaplastic Thyroid Cancer: Systematic Review and Pooled Analysis (2020) (8)
- A Monte-Carlo study to assess the effect of 1.5T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer. (2017) (8)
- Effects of ionizing radiation in combination with Erufosine on T98G glioblastoma xenograft tumours: a study in NMRI nu/nu mice (2012) (8)
- Dose optimization of total or partial skin electron irradiation by thermoluminescent dosimetry (2018) (8)
- Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis (2020) (8)
- Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma (2021) (8)
- TSPO-PET for glioma imaging using the novel ligand [F-18]GE-180-first in human results in high-grade glioma patients (2017) (8)
- Stereotactic radiotherapy of intrapulmonary lesions: comparison of different dose calculation algorithms for Oncentra MasterPlan® (2015) (8)
- Porcine lung phantom-based validation of estimated 4D-MRI using orthogonal cine imaging for low-field MR-Linacs (2020) (8)
- Evaluation of the role of remission status in a heterogeneous limited disease small-cell lung cancer patient cohort treated with definitive chemoradiotherapy (2016) (8)
- Targeting death-receptors in radiation therapy. (2009) (8)
- PSMA-positive nodal recurrence in prostate cancer (2020) (8)
- Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer (2020) (8)
- A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer (2017) (7)
- External-beam radiation therapy combined with limb-sparing surgery in elderly patients (>70 years) with primary soft tissue sarcomas of the extremities (2017) (7)
- Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions. (1999) (7)
- Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting (2019) (7)
- Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [18F]FMISO PET/CT. (2022) (7)
- Tumor-specific delivery of 5FU-incorporated EGFR-targeted aptamers as an efficient treatment in pancreatic ductal adenocarcinoma models. (2021) (7)
- Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation (2019) (7)
- Efficacy of triple therapies including ionising radiation, agonistic TRAIL antibodies and cisplatin. (2009) (7)
- Timing of failure in limited disease (stage I-III) small-cell lung cancer patients treated with chemoradiotherapy: a retrospective analysis. (2013) (6)
- Variance-based sensitivity analysis for uncertainties in proton therapy: A framework to assess the effect of simultaneous uncertainties in range, positioning and RBE model predictions on RBE-weighted dose distributions. (2020) (6)
- PO-0646: Temozolomide during radiotherapy of glioblastoma multiforme: daily administration improves survival (2016) (6)
- Patient-specific CT calibration based on ion radiography for different detector configurations in 1H, 4He and 12C ion pencil beam scanning (2020) (6)
- Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis (2020) (6)
- Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study (2021) (6)
- Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer – a prospective pilot study (2020) (6)
- Intensity-Modulated Radiotherapy for a Rendu-Osler-Weber Disease Patient with Recurrent Severe Epistaxis: A Case Report (2010) (6)
- Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy (2013) (6)
- Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey (2020) (6)
- Optimization of Phase Space files from clinical linear accelerators. (2018) (6)
- Endometrial cancer - reduce to the minimum. A new paradigm for adjuvant treatments? (2011) (6)
- Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer (2020) (6)
- A novel method for interactive multi-objective dose-guided patient positioning (2017) (5)
- Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer (2021) (5)
- Forging a Path for Metformin Use in Inoperable Locally Advanced Non-Small Cell Lung Cancer. (2021) (5)
- Therapy-related transcriptional subtypes in matched primary and recurrent head and neck cancer. (2021) (5)
- Risk of biochemical recurrence and timing of radiotherapy in pT3a N0 prostate cancer with positive surgical margin (2016) (5)
- Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2) (2020) (5)
- Dosimetric impact of deep learning-based CT auto-segmentation on radiation therapy treatment planning for prostate cancer (2022) (5)
- Cystosarcoma phyllodes malignum: a case report of a successive triple modality treatment (2000) (5)
- Linearity of patient positioning detection (2015) (5)
- Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study (2020) (5)
- MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience (2022) (5)
- Comparison of GeneChip, nCounter and real-time polymerase chain reaction based gene expressions predicting loco-regional tumour control after primary and postoperative radiochemotherapy in head and neck squamous cell carcinoma. (2020) (5)
- Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapy (2020) (5)
- Deformable image registration of the treatment planning CT with proton radiographies in perspective of adaptive proton therapy (2020) (5)
- Late and very late catch-up after 90Sr/90Y beta-irradiation for the treatment of coronary in-stent restenosis (2011) (5)
- Secondary hormonal manipulation. (2008) (5)
- PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook (2021) (5)
- Medulloblastoma in adults (2017) (5)
- Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - hypothesis generation on a multicentre cohort of the DKTK-ROG. (2022) (5)
- Neoadjuvant chemoradiation for esophageal cancer (2018) (5)
- Use of diffusion-weighted MRI to modify radiosurgery planning in brain metastases may reduce local recurrence (2016) (5)
- Magnetic resonance-guided radiation therapy: the beginning of a new era (2020) (5)
- Dosimetric impact of intrafraction motion on boosts on intraprostatic lesions: a simulation based on actual motion data from real time ultrasound tracking (2019) (4)
- [The use of sucralfate in radiation oncology]. (1997) (4)
- Deep learning based time-to-event analysis with PET, CT and joint PET/CT for head and neck cancer prognosis (2022) (4)
- Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas (2020) (4)
- ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy (2020) (4)
- Concurrent radiotherapy and nivolumab in metachronous metastatic primary adenosquamous-cell carcinoma of the prostate. (2018) (4)
- Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review (2022) (4)
- MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF (2021) (4)
- Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer. (2016) (4)
- OC-0375: Hypoxia dose-escalation with chemoradiation in head and neck cancer: planned interim analysis of a randomized study (2014) (4)
- Clinical workflow optimization to improve 4DCT reconstruction for Toshiba Aquilion CT scanners. (2018) (4)
- LEOPARD-II: A randomized phase II study of radiochemotherapy (RCT) with 5FU and cisplatin plus/minus cetuximab (Cet) in unresectable locally advanced esophageal cancer (LAEC). (2014) (4)
- Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition (2021) (4)
- Mutational patterns of HPV+ and HPV- squamous cell carcinomas of the head and neck (SCCHN) and their interference with outcome after adjuvant chemoradiation: A multicenter biomarker study of the German Cancer Consortium Radiation Oncology Group. (2015) (4)
- [Image-guided radiation therapy]. (2012) (4)
- Measurement-based range evaluation for quality assurance of CBCT-based dose calculations in adaptive proton therapy. (2021) (4)
- A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer (2021) (4)
- Tomographic imaging with carbon ion beams (2016) (4)
- Experimental thermoradiotherapy in malignant hepatocellular carcinoma. (2003) (4)
- [Recurrence of prostate cancer--value of salvage radiotherapy]. (2006) (4)
- MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC) (2022) (4)
- Surface refraction of sound waves affects calibration of three-dimensional ultrasound (2015) (4)
- Radiotherapy in oncological emergencies: fast-track treatment planning (2020) (4)
- Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study (2018) (4)
- Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations (2021) (4)
- HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience (2021) (4)
- Primary non-small cell lung cancer in a transplanted lung treated with stereotactic body radiation therapy (2014) (4)
- Soluble levels of CD-95, CD 95-L and various cytokines after exposing human leukocytes to ionizing radiation. (2000) (3)
- Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy (2022) (3)
- [Clinical value of mammography, ultrasound and MR imaging during the first year after breast conserving therapy of breast cancer]. (2004) (3)
- Prophylactic Cranial Irradiation for Patients with Small Cell Lung Cancer in Germany: Pattern of Care Survey (2018) (3)
- Longitudinal [18F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model (2022) (3)
- External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy (2020) (3)
- A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa (2021) (3)
- Accounting for prompt gamma emission and detection for range verification in proton therapy treatment planning (2020) (3)
- Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer (2019) (3)
- Fluence-modulated proton CT optimized with patient-specific dose and variance objectives for proton dose calculation (2021) (3)
- Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy (2020) (3)
- Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial) (2016) (3)
- A new treatment planning approach accounting for prompt gamma range verification and interfractional anatomical changes (2020) (3)
- Practical implications for the quality assurance of modulated radiation therapy techniques using point detector arrays (2017) (3)
- X-ray CT adaptation based on a 2D–3D deformable image registration framework using simulated in-room proton radiographies (2022) (3)
- Single-center versus multi-center data sets for molecular prognostic modeling: a simulation study (2020) (3)
- Improving the modelling of susceptibility-induced spatial distortions in MRI-guided extra-cranial radiotherapy (2019) (3)
- Intra-fraction motion of the prostate is not increased by patient couch shifts (2016) (3)
- [OA127] Cone-beam CT intensity correction for adaptive radiotherapy of the prostate using deep learning (2018) (3)
- A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer (2022) (3)
- Analyses of molecular subtypes and their association to mechanisms ofradioresistance in patients with HPV-negative HNSCC treated bypostoperative radiochemotherapy. (2022) (3)
- Treatment planning and evaluation of gated radiotherapy in left-sided breast cancer patients using the CatalystTM/SentinelTM system for deep inspiration breath-hold (DIBH) (2016) (3)
- MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy (2022) (3)
- Patient-Reported and Oncological Outcomes of Salvage Therapies for PSMA-Positive Nodal Recurrent Prostate Cancer: Real-Life Experiences and Implications for Future Trial Design (2021) (3)
- Recommendations for Radiation Therapy in Oligometastatic Prostate Cancer: an ESTRO-ACROP Delphi consensus. (2022) (3)
- 18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization (2022) (3)
- Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium - Radiation Oncology Group (DKTK-ROG). (2022) (3)
- Priming of Anti-tumor Immune Mechanisms by Radiotherapy Is Augmented by Inhibition of Heat Shock Protein 90 (2020) (3)
- Combining inter-observer variability, range and setup uncertainty in a variance-based sensitivity analysis for proton therapy (2021) (3)
- Investigating a Correlation between Chemoradiotherapy Schedule Parameters and Overall Survival in a real-life LD SCLC Patient Cohort (2016) (3)
- Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition (2021) (3)
- Risk Stratification Using 18F-FDG PET/CT and Artificial Neural Networks in Head and Neck Cancer Patients Undergoing Radiotherapy (2021) (3)
- Modeling RBE-weighted dose variations in irregularly moving abdominal targets treated with carbon ion beams. (2020) (3)
- 215 In vitro and in vivo effects after combined treatment of colorectal tumors with apoptosis inducing trail receptor antibodies hgs-etr1 and HGS-ETR2 and radiotherapy (2006) (3)
- Offline and online LSTM networks for respiratory motion prediction in MR-guided radiotherapy (2022) (3)
- TH-CD-202-05: DECT Based Tissue Segmentation as Input to Monte Carlo Simulations for Proton Treatment Verification Using PET Imaging. (2016) (3)
- Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas (2021) (3)
- MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients (2022) (3)
- Radiation to the Primary Tumor in Metastatic Anaplastic Thyroid Cancer (2021) (3)
- Biological Basis of Combined Radio- and Chemotherapy (2006) (3)
- No evidence for sequences structurally related to the RB1 gene in the human genome (1991) (3)
- The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis (2022) (3)
- APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases (2022) (3)
- Anthropomorphic lung phantom based validation of in-room proton therapy 4D-CBCT image correction for dose calculation (2020) (2)
- Improved risk stratification in younger IDH wild-type glioblastoma patients by combining a 4-miRNA signature with MGMT promoter methylation status (2020) (2)
- Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial (2022) (2)
- Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin’s lymphoma: a monocenter analysis (2021) (2)
- PV-0044 Mastectomy or breast-conserving therapy for early breast cancer: outcome comparison of 7565 cases (2019) (2)
- Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas (2020) (2)
- Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET. (2020) (2)
- A deep image-to-image network organ segmentation algorithm for radiation treatment planning: principles and evaluation (2022) (2)
- Validation of proton dose calculation on scatter corrected 4D cone beam computed tomography using a porcine lung phantom (2021) (2)
- Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma (2021) (2)
- Dosimetric impact of geometric distortions in an MRI-only proton therapy workflow for lung, liver and pancreas (2020) (2)
- Three-dimensional surface imaging in breast cancer: a new tool for clinical studies? (2020) (2)
- Efficacy of re-irradiation with carbon ions (RiCi) in patients with recurrent high-grade glioma (rHGG) compared to the standard re-irradiation with photons (RiP): The reference multicenter cohort of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2019) (2)
- Differential protection by wildtype vs. organelle-specific Bcl-2 suggests a combined requirement of both the ER and mitochondria in ceramide-mediated caspase-independent programmed cell death (2009) (2)
- Real-time intra-fraction motion management in breast cancer radiotherapy: analysis of 2028 treatment sessions (2018) (2)
- Clinical Outcome and Toxicity in the Treatment of Anaplastic Thyroid Cancer in Elderly Patients (2020) (2)
- Tumor microenvironment characterization in head and neck squamous carcinoma reveals distinct genomic alterations and clinical outcomes (2020) (2)
- Discovery of a reliable and robust methylome classifier of HPV driven head and neck cancer with favorable response to chemoradiation: A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2018) (2)
- [Multimodal treatment strategy for Langerhans cell histiocytosis at head and neck manifestations]. (2003) (2)
- Radiation Therapy and Apoptosis (2008) (2)
- Feasibility of hypofractionated radiotherapy in inoperable node-positive NSCLC patients with poor prognostic factors and limited pulmonary reserve: a prospective observational study (2021) (2)
- Radiotherapy in the Treatment of Langerhans Cell Histiocytosis (2000) (2)
- Interference between mutational load, immune signatures and outcome in patients with head and neck cancer treated with definitive chemoradiation: A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2018) (2)
- PO-0909: Merging proton radiographies with treatment planning CT for adaptive radiation therapy (2016) (2)
- [A special radiation shielding for the radiotherapy of a pregnant patient]. (2008) (2)
- LIPOPOLYSACCHARIDE INDUCES ACTIVATION OF THE INTERLEUKIN 1 CONVERTING ENZYME (ICE) IN MONOCYTIC AND ENDOTHELIAL CELLS: 82 (1997) (2)
- A 2D-3D Deformable Image Registration Framework for Proton Radiographies in Adaptive Radiation Therapy (2019) (2)
- Prostate intra-fraction motion data recorded by transperineal ultrasound (ProMotion LMU dataset) (2019) (2)
- [Quantitative assessment of therapy related effects after breast conserving therapy with dynamic MRI of the breast]. (2001) (2)
- Interstitial High-Dose-Rate Brachytherapy of Liver Metastases in Oligometastatic Patients (2021) (2)
- Connective tissue growth factor (CTGF) methylation status is associated with prognosis of patients with head and neck squamous cell carcinoma (HNSCC) treated with radiochemotherapy (RCHT): A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2019) (1)
- [Radiotherapy in prostate cancer]. (2008) (1)
- Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia (2022) (1)
- Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial (2019) (1)
- [Oral sucralfate administration for therapy and prevention of radiation-induced esophagitis: results of a placebo-controlled double-blind study]. (1998) (1)
- Individualisation of radiochemotherapy (RTCT) for locally advanced non-small cell lung cancer (NSCLC) (2014) (1)
- A Privacy-Preserving Log-Rank Test for the Kaplan-Meier Estimator With Secure Multiparty Computation: Algorithm Development and Validation (2021) (1)
- Mitomycin C and fractionated radiotherapy: Potentiation of response and inhibition of repopulation (2000) (1)
- FET-PET for radiotherapy planning in malignant glioma (2011) (1)
- Hippocampal EUD in primarily irradiated glioblastoma patients (2014) (1)
- The ProMotion LMU dataset, prostate intra-fraction motion recorded by transperineal ultrasound (2019) (1)
- Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas (2018) (1)
- [Role of radiotherapy in induction of myeloid secondary neoplasms after high dosage therapy of malignant lymphomas]. (2001) (1)
- Validation of the prognostic Heidelberg re-irradiation score in an independent mono-institutional patient cohort (2014) (1)
- Single-isocenter stereotactic radiosurgery for multiple brain metastases: Impact of patient misalignments on target coverage in non-coplanar treatments (2022) (1)
- [Retroperitoneal soft tissue sarcoma: role of radiotherapy]. (2021) (1)
- Simultaneous bilateral stereotactic body radiation therapy of two inoperable centrally located pulmonary lesions in a patient with metastatic mesenchymal chondrosarcoma (2016) (1)
- 971 Additive and synergistic effects on TRAIL/Apo2L induced apoptosis after irradiation and eradication of clonogenic cells in solid tumor cell lines in vitro (2003) (1)
- Analysis of genetic variants of frequently mutated genes in HPV-negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell-free DNA. (2022) (1)
- Estimation of the a / b ratio of non-small cell lung cancer treated with stereotactic body radiotherapy (2019) (1)
- PD-0909 Outcomes of metastasis-directed treatment of bone oligometastatic disease in prostate cancer (2021) (1)
- 651 Effects of celecoxib and irradiation treatment on prostate cancer cell lines (2004) (1)
- 68PD CHEMORADIOTHERAPY DURATION CORRELATES WITH OVERALL SURVIVAL IN LIMITED-DISEASE SMALL-CELL LUNG CANCER PATIENTS WITH POOR INITIAL PERFORMANCE STATUS WHO SUCCESSFULLY COMPLETED MULTIMODALITY TREATMENT (2011) (1)
- Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics (2021) (1)
- Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors (2013) (1)
- Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated γ-irradiation (2014) (1)
- Role of the tyrosine kinase lck for the induction of apoptosis in response to ionizing radiation (2001) (1)
- Iodine-125 brachytherapy for brain tumours - a review (2012) (1)
- Post-processing sets of tilted CT volumes as a method for metal artifact reduction (2014) (1)
- Dosimetric Impact of Deep Learning-Based CT Auto-Segmentation on IMRT Treatment Planning for Prostate Cancer (2021) (1)
- Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol fo (2021) (1)
- Feasibility of 6 Months Maintenance Cetuximab After Adjuvant Concurrent Chemoradiation Plus Cetuximab in Squamous Cell Carcinoma of the Head and Neck (2013) (1)
- Novel modified patient immobilisation device with an integrated coil support system for MR-guided online adaptive radiotherapy in the management of brain and head-and-neck tumours (2021) (1)
- 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study (2022) (1)
- INCLUSION OF UNCERTAINTIES IN MULTIPARAMETRIC MR IMAGING INTO DOSE PAINTING FOR PROSTATE TUMOURS (2009) (1)
- Timing of Radiotherapy after Radical Prostatectomy: Effects on Health-Related Quality of Life (2021) (1)
- Impact of MLC properties and IMRT technique in meningioma and head-and-neck treatments (2012) (1)
- A patient-specific hybrid phantom for calculating radiation dose and equivalent dose to the whole body (2021) (1)
- Optimizing the Analytical Value of Oncology-Related Data Based on an In-Memory Analysis Layer: Development and Assessment of the Munich Online Comprehensive Cancer Analysis Platform (2020) (1)
- [Immuncheckpoint Inhibitors: Current Indications and Possible Future Concepts]. (2018) (1)
- EP-1635: Framework for the evaluation of interplay effects between respiratory motion and dose application (2017) (1)
- In the linear quadratic model, the Poisson approximation and the Zaider-Minerbo formula agree on the ranking of tumor control probabilities, up to a critical cell birth rate (2017) (1)
- EP-1333: Re-recurrence pattern after re-irradiation with bevacizumab in recurrent malignant glioma (2015) (1)
- Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy. (2022) (1)
- ExacTrac Dynamic workflow evaluation: Combined surface optical/thermal imaging and X‐ray positioning (2022) (1)
- PD-0428: Targeting HSP90 with the novel inhibitor NW457 attenuates radioresistance of human glioblastoma cells (2014) (1)
- OC-0508: Identification of tumour sub-volumes for improved radiomic risk modelling in locally advanced HNSCC (2018) (1)
- Patient positioning and immobilization procedures for hybrid MR-Linac systems (2021) (1)
- Single isocenter stereotactic radiosurgery for patients with multiple brain metastases: dosimetric comparison of VMAT and a dedicated DCAT planning tool (2019) (1)
- Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis (2023) (1)
- ESTRO ACROP guidelines for the delineation of lymph nodal areas in upper gastrointestinal malignancies. (2021) (1)
- Meningeal Involvement in Acute Leukaemia and High-Grade Non-Hodgkin’s Lymphoma is Associated with Elevated Activities of Galactosyltransferases in the Cerebrospinal Fluid (1994) (1)
- Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab (2022) (1)
- The impact of residual metabolic primary tumor volume after completion of thoracic irradiation in patients with inoperable stage III NSCLC. (2020) (1)
- X-change symposium: status and future of modern radiation oncology—from technology to biology (2021) (1)
- Evaluation of daily patient positioning for radiotherapy with a commercial 3D surface-imaging system (Catalyst™) (2016) (1)
- Abstract ID: 144 An equipment-specific Geant4 model for the Elekta Agility collimator (2017) (1)
- Quantitative Cell Kill of Radio- and Chemotherapy (2009) (1)
- [Management of prostate cancer]. (2012) (1)
- PO-1004 Simulation of tissue dependent magnetic field susceptibility effects in MRI guided radiotherapy (2019) (1)
- PO-1092 A novel, efficient contour mapping method facilitates adaptive radiotherapy in head and neck patients (2015) (1)
- A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT (2022) (1)
- Prophylactic cranial irradiation after reaching complete response, partial response, or stable disease in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors (ProACT). (2012) (1)
- Evaluation of an anthropomorphic ion chamber and 3D gel dosimetry head phantom at a 0.35 T MR-linac using separate 1.5 T MR-scanners for gel readout (2022) (1)
- Immunological aspects of radiotherapy (2014) (1)
- Integration of Spatial Distortion Effects in a 4D Computational Phantom for Simulation Studies in Extra-Cranial MRI-guided Radiation Therapy: Initial Results. (2020) (1)
- Radiotherapy in oligometastatic prostate cancer—a pattern of care survey among members of the German Society for Radiation Oncology (DEGRO) (2022) (1)
- Neoadjuvant Chemotherapy Plus Regional Hyperthermia and Long-termOutcomes Among PatientsWith Localized High-Risk Soft Tissue Sarcoma The EORTC 62961-ESHO 95 Randomized Clinical Trial (2017) (1)
- Assessment of intrafractional prostate motion and its dosimetric impact in MRI-guided online adaptive radiotherapy with gating. (2022) (1)
- Docetaxel/cisplatin alternating with re-irradiation in recurrent head and neck cancer (2005) (1)
- Validation of the collapsed cone algorithm for HDR liver brachytherapy against Monte Carlo simulations. (2021) (1)
- Analysis of equivalent uniform dose (EUD) and conventional radiation treatment parameters after primary and re-irradiation of malignant glioma (2013) (1)
- MP62-18 SURVIVAL AFTER RADICAL PROSTATECTOMY OR RADIOTHERAPY AS PRIMARY TREATMENT IN PATIENTS WITH NON-METASTASIZED PROSTATE CANCER (2015) (1)
- 18F-GE-180 TSPO PET in High-Grade Glioma RT Planning. (2021) (1)
- Timing of Failure in Limited Disease (Stage I-III) Small-Cell Lung Cancer Patients Treated with Chemoradiotherapy: A Retrospective Analysis (2013) (1)
- SP-0032: Enabling proton dose calculations on CBCT images (2018) (1)
- Clinical outcome after multicenter, open-label phase II trial on post-surgery chemoradiation in combination with cetuximab in squamous cell carcinoma of the head and neck with high risk of locoregional recurrence. (2016) (1)
- Clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer. (2022) (1)
- Salvage Therapies for PSMA PET/CT-positive nodal-only recurrent prostate cancer: Impact on survival, functional outcomes and health-related quality of life (2021) (0)
- Corrigendum to “HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)” [Radiother. Oncol. (2015) (0)
- [OA051] Toward a new treatment planning system accounting for in-vivo proton range verification in proton therapy (2018) (0)
- Maximum treatment response and prophylactic cranial irradiation are important prognostic factors in limited disease small‐cell lung cancer patients comprehensively staged with cranial magnetic resonance imaging: 127P (2016) (0)
- Prognostic impact of inflammatory profiling during and after multimodal treatment for stage III NSCLC. (2021) (0)
- PO-0686 EUD BASED IMRT FOR PROSTATE CANCER IN 173 PATIENTS – TOXICITIES AND CORRELATING DOSE-VOLUME-HISTOGRAMS (2012) (0)
- Importance of Bak/Bax for Efficacy of Radiochemotherapy in Colorectal Cancer (2007) (0)
- [Image-guided radiation therapy. Paradigm change in radiation therapy]. (2012) (0)
- MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience (2022) (0)
- of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent (2019) (0)
- PD-0568: Investigation of the optimal design of IMRT QA tests with regard to the properties of the MLC and the measurement device (2013) (0)
- OC-0496 Deep-learning based estimation of locoregional control for patients with locally advanced HNSCC (2019) (0)
- Pharmaceutical kinetics and bio-availability of Erufosine in the nude-mouse model. (2008) (0)
- Combination of the TRAIL death ligand and ionizing radiation (2000) (0)
- 126 Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node optimized target volume definition (2006) (0)
- OC-0433 Feasibility and early clinical response of interstitial BT for hepatocellular carcinoma (2019) (0)
- Early efficacy of Ga-68-PSMA PET/CT based radiotherapy in patients with biochemical failure or persistence after radical prostatectomy (2017) (0)
- PO-0629: A 4-miRNA signature predicts the therapeutic outcome of glioblastoma (2017) (0)
- Dosimetric impact of intrafraction motion on boosts on intraprostatic lesions: a simulation based on actual motion data from real time ultrasound tracking (2019) (0)
- Current status and perspectives of interventional clinical trials for glioblastoma – analysis of ClinicalTrials.gov (2017) (0)
- On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model (2016) (0)
- Radiotherapy of oligometastatic prostate cancer: a systematic review (2021) (0)
- EP-1073: Validation of the Heidelberg prognostic reirradiation score in an independent patient cohort (2014) (0)
- Cathepsin D expression mediates gemcitabine resistance in pancreatic cancer (2019) (0)
- PO-1029: Preliminary analysis of patient cohorts treated pre vs post approval of consolidation IO in LANSCLC (2020) (0)
- PD-0812 Brachytherapy of locally advanced cervical cancer using the hybrid applicator VeneziaTM - results (2021) (0)
- Association of planning target volume with disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition. (2021) (0)
- Effects of ionizing radiation in combination with Erufosine on T98G glioblastoma xenograft tumours: a study in NMRI nu/nu mice (2012) (0)
- PO-1328 Prospective assesment of quality of life before, during and after CRT in patients with anal cancer (2022) (0)
- Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images (2016) (0)
- PO-0736: Pattern of failure after sentinel node based individualization of pelvic IMRT for high risk prostate cancer (2014) (0)
- First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments (2020) (0)
- SU-F-J-214: Dose Reduction by Spatially Optimized Image Quality Via Fluence Modulated Proton CT (FMpCT). (2016) (0)
- Increased CD44v6 expression confers radioresistance in subsets of HNSCC (2017) (0)
- Pooled analysis on image‐guided moderately hypofractionated thoracic irradiation in inoperable node‐positive/recurrent patients with non–small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve (2022) (0)
- Evaluation of real-time tumor contour prediction using LSTM networks for MR-guided radiotherapy. (2023) (0)
- OC-0277 A 6-gene signature for loco-regional control prognosis in HNSCC patients treated by PORT-C (2021) (0)
- 117P Feasibility of moderate hypofractionated image-guided thoracic irradiation for locally advanced node-positive non-small cell lung cancer patients with very limited lung function (2018) (0)
- Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC (2022) (0)
- OC-0446: Senescence and associated cytokines are critical drivers of inherent radioresistance in HNSCC (2020) (0)
- Fast automated non-linear contour propagation for adaptive head and neck radiotherapy (2016) (0)
- Molecular Mechanisms of Ara-C Signalling: Synergy and Antagonism with Interleukin-3 (1996) (0)
- PO-0999: Deciphering the tumor microenviroment based on PD-L1 expression and CD8 + TILs density in LA-NSCLC (2020) (0)
- EP-1239: SBRT in patients with HCC/CCC or oligometastatic liver disease (2017) (0)
- MO-FG-CAMPUS-JeP1-04: Evaluating DECT Vs SECT Range Differences in Proton Therapy Using Clinical Data. (2016) (0)
- Surface refraction of sound waves affects calibration of three-dimensional ultrasound (2015) (0)
- 114P Evaluation of pulmonary function parameters after moderate hypofractionated image-guided thoracic irradiation in locally advanced node-positive non-small cell lung cancer patients with very limited lung function (2018) (0)
- [OA010] A 4D Monte Carlo (MC) dose calculation framework with statistical breathing phase sampling to quantify interplay effects (2018) (0)
- Superior Prognostic Performance of an Immunohistochemistry Trained DNA-Methylation Based PD-L1 Score in Patients with HNSCC Treated with Radiochemotherapy: A Multicenter Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2020) (0)
- Abstract ID: 138 Fluence modulated proton computed tomography (2017) (0)
- Ex-vivo testing and preclinical heterotopic thoracic cardiac xenotransplantation of multi-transgenic organs (2014) (0)
- PO-0740: Nodal clearance rate and efficacy of individualised SN-based pelvic IMRT for prostate cancer (2016) (0)
- PO-0906 Perturbation techniques for optimizing IAEA phase spaces for different medical linacs (2019) (0)
- PO-0736 Radiation necrosis after a combination of EBRT and iodine-125 brachytherapy in gliomas (2019) (0)
- EP-1081 LOCO-REGIONAL CONTROL AFTER RADIOCHEMOTHERAPY FOR ANAL CANCER: A SINGLE CENTRE RETROSPECTIVE ANALYSIS (2012) (0)
- Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients (2015) (0)
- The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy (2020) (0)
- Quantitative investigation of the potential of ion computed tomography for clinical ion therapy treatment planning (2018) (0)
- EP-1124: PET-MRI prior to re-irradiation of high-grade glioma patients - a planning study (2017) (0)
- 73PDPrognostic value of pre- to post-treatment primary tumor metabolic volume reduction on 18F-FDG-PET/CT in a patient cohort with inoperable locally-advanced NSCLC treated with definitive chemoradiotherapy (2017) (0)
- A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [Formula: see text]F]FDG PET/CT. (2023) (0)
- FET-PET recurrence pattern after radio-chemotherapy in patients with glioblastoma (2011) (0)
- OC-0588: Validation of the reRT risk score (RRRS) in glioma patients: A multicenter DKTK/ROG analysis (2018) (0)
- Evaluation of the role of remission status in a heterogeneous limited disease small-cell lung cancer patient cohort treated with definitive chemoradiotherapy (2016) (0)
- Stereotactic radiotherapy of intrapulmonary lesions: comparison of different dose calculation algorithms for Oncentra MasterPlan® (2015) (0)
- Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy (2023) (0)
- 3D MR spectroscopic and diffusion-weighted imaging of prostate cancer with phased-array surface coil at 3 T for tumor definition in the intensity-modulated radiation therapy (2008) (0)
- EP-1375 Heterogeneity score in inoperable stage III NSCLC patients treated with definitive chemoradiotherapy (2019) (0)
- 279 Durvalumab after chemoradiotherapy for PD-L1 expressing inoperable stage III NSCLC impacts local-regional control and overall survival (2020) (0)
- EP-1412 Excellent pCR rate in patients with HCC after SBRT +/-TACE as bridging to liver transplantation (2019) (0)
- Wound monitoring of pH and oxygen in patients after radiation therapy (2019) (0)
- Diverging metabolic patterns on [18F]FDG PET/CT in inoperable stage III NSCLC patients undergoing anti-PD-L1 checkpoint inhibition with durvalumab (2023) (0)
- l Clinical Investigation RADIOTHERAPY AND CONCOMITANT WEEKLY l-HOUR INFUSION OF PACLITAXEL IN THE TREATMENT OF HEAD AND NECK CANCER- RESULTS FROM A PHASE I TRIAL (1997) (0)
- Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases (2018) (0)
- MP46-17 THE IMPACT OF PATHOLOGICAL GLEASON SCORE ON BIOCHEMICAL RECURRENCE IN PATIENTS WITH PATHOLOGICALLY ORGAN-CONFINED T2 PROSTATE CANCER AND POSITIVE SURGICAL MARGINS: CAN WE JUSTIFY EXPECTANT MANAGEMENT OR IS ADJUVANT RADIATION THERAPY INDICATED? RESULTS OF A MULTICENTER EUROPEAN EVALUATION (2014) (0)
- An offline tool for retrospective reconstruction of 4DCTs using Sentinel and Toshiba CT (2015) (0)
- OC-0525 4D Monte Carlo dose calculations on different CT image sets for SBRT using patient breathing data (2019) (0)
- 943 POSTER IMRT based radiosurgery – a planning study (2007) (0)
- Hippocampal sparing radiotherapy for glioblastoma patients: a planning study using volumetric modulated arc therapy (2016) (0)
- Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT (2013) (0)
- EP-1489: Outcome after neoadjuvant chemoradiation in elderly patients (≥ 70 years) with rectal cancer (2018) (0)
- Mammary Chain Irradiation in Left-Sided Breast Cancer: Can We Reduce the Risk of Secondary Cancer and Ischaemic Heart Disease with Modern Intensity-Modulated Radiotherapy Techniques? (2020) (0)
- OC-0619: Targeting HSP90 with the small-molecule inhibitor NW457 sensitizes human glioblastoma cells to ionizing radiation (2015) (0)
- [F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful? (2020) (0)
- Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study (2020) (0)
- Abstract #5492: Dihydroartemisinin is a potent anticancer drug active in hypoxic conditions (2009) (0)
- Correction: A deep image-to-image network organ segmentation algorithm for radiation treatment planning: principles and evaluation (2022) (0)
- 81 Synergistic effects of Apo-2L/TRAIL and ionizing irradiation in human tumor cell lines without relevant damage of normal tissue cells (2004) (0)
- PO-0958: Neoadjuvant RT followed by mastectomy and immediate breast reconstruction: updated 5-years results (2020) (0)
- 84P Impact of PTV on progression-free survival in inoperable stage III non-small cell lung cancer patients treated with chemoradioimmunotherapy (2021) (0)
- A deep image-to-image network organ segmentation algorithm for radiation treatment planning: principles and evaluation (2022) (0)
- Feasibility of CycleGAN enhanced low dose CBCT imaging for prostate radiotherapy dose calculation. (2023) (0)
- OC-0060 Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia (2021) (0)
- Diagnose „Prostatakarzinom“ (2013) (0)
- Radiation Oncology reviewer acknowledgment 2012 (2013) (0)
- PD-0455: Investigating a correlation between chemoradiotherapy schedule and survival in limited disease SCLC (2013) (0)
- 84P Patterns of care for patients with small cell lung cancer: A survey of German radiation oncology institutions on recommendations for prophylactic cranial irradiation (2018) (0)
- EP-1319: Long-term results of partial-breast-IORT or IORT-boost: a 10-year mono-institutional experience (2018) (0)
- Radiation-Induced Lung Injury: Prevention, Diagnostics and Therapy in the Era of the COVID-19 Pandemic (2022) (0)
- Current status and recent advances in reirradiation of glioblastoma (2021) (0)
- Longitudinal analysis of dynamic changes of T-lymphocytes during multimodal treatment of patients with inoperable stage III NSCLC. (2021) (0)
- EP-1789: Sensitivity analysis of EPID-based 3D dose reconstruction for VMAT QA (2018) (0)
- Propensity score matching analysis of patients with inoperable stage III NSCLC treated with chemoradio- vs. chemoradioimmunotherapy. (2020) (0)
- Intensity Modulated Radiotherapy for High Risk Prostate Cancer Based on Sentinel Node Optimized Target Volume Definition (2005) (0)
- Combination of the TRAIL death ligand with ionizing radiation — rationale and efficacy (2001) (0)
- EP-1445: Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing CRT (2018) (0)
- Utilizing CBCT data for dose calculation in adaptive IMPT (2016) (0)
- PO-1329 Longterm Biochemical Recurrence-Free Survival after PSMA-PET/CT–Based Salvage Radiotherapy (2021) (0)
- The ProMotion LMU dataset (2022 edition), prostate intra-fraction motion recorded by transperineal ultrasound (2022) (0)
- PO-0622: Medulloblastoma in adults: a retrospective single institution analysis (2017) (0)
- SP-0144: Introducing the ESMO-ESTRO-ESSO clinical guideline on anal cancer (2014) (0)
- Independent validation of a prognostic 4-miRNA signature in de novo glioblastoma (2017) (0)
- EP-1745: Patient positioning by 3D ultrasound: quantification of inherenttechnical limitations (2014) (0)
- Radiotherapy in oncological emergencies: fast-track treatment planning (2020) (0)
- PO-1167: Salvage therapies for PSMA PET-positive nodal recurrent prostate cancer (2020) (0)
- Improved proton stopping power ratio estimation for a deformable 3D dosimeter using Dual Energy CT (2016) (0)
- Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients (2014) (0)
- EP-2059: Real time optical surface IGRT: A mono-institutional prospective study of 110 patients (2018) (0)
- Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid) (2015) (0)
- PH-0165 Differentiation of Pseudoprogression vs. True Progressive Disease using Contrast Clearance Analysis (2021) (0)
- EP-1563 PSMA-ligand based radiotherapy for lymph node relapsed prostate cancer after radical prostatectomy (2019) (0)
- EP-1804: A comparative analyse of prostate positioning guided by transperineal 3D ultrasound and cone beam CT (2016) (0)
- Towards real-time EPID-based 3D in-vivo dosimetry using machine learning (2021) (0)
- PD-0912 Outcome of PSMA-PET/CT based salvage radiotherapy for nodal recurrence after radical prostatectomy (2021) (0)
- PO-1397 Quality of life in prostate cancer patients treated with a definitive radiotherapy (2022) (0)
- EP-1122: TSPO PET imaging RT treatment planning in malignant glioma (2017) (0)
- [Neoadjuvant radiochemotherapy for rectal cancer]. (2011) (0)
- Current status of radiotherapy/radiochemotherapy and immunotherapy combinations– a German survey (2018) (0)
- Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy (2013) (0)
- Magnetic resonance-guided radiation therapy: the beginning of a new era (2020) (0)
- PO-0723: TSPO-PET for RT treatment planning using [18F]GE-180 – first in human results in GBM p atients (2018) (0)
- EP-1034 COMBINATION OF PERCUTANEOUS RADIOTHERAPY AND IODINE-125 BRACHYTHERAPY IN RECURRING BRAIN TUMOURS (2012) (0)
- OC-0488: Prognostic biomarkers and targets for personalization of radiotherapy of HNSCC: CD44v6 (2018) (0)
- Comparison of hyperfractionated radiotherapy with conventionally fractionated radiotherapy (Group 3) (2011) (0)
- EP-2027: Fractionated radiotherapy plus anti-angiogenic therapy in an orthotopic glioma transplantation model (2016) (0)
- PO-0644 RE-IRRADIATION IN RECURRENT MALIGNANT GLIOMA – PREDICTIVE VALUE OF [18F]FET-PET (2012) (0)
- Discovery ydroartemisinin Induces Apoptosis by a Bak-Dependent Ther insic Pathway (2010) (0)
- ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer. (2023) (0)
- Impact of thrombocytosis and neutrophil-to-lymphocyte ratio before start of chemoradiotherapy on patient survival in inoperable stage III NSCLC. (2019) (0)
- [Radiotherapy of rectal cancer]. (2012) (0)
- PO-0893: Radiation therapy in meningioma- single center prospective and retrospective analysis (2020) (0)
- PD-0810 Salvage Therapies for PSMA PET/CT-positive nodal-only recurrent prostate cancer: Impact on survival, functional outcomes and health-related quality of life (2021) (0)
- 71 IGRT of the prostate with mr spectroscopy, 11C-choline and sentinel node imaging (2006) (0)
- A comparative assessment of prostate positioning guided by three-dimensional ultrasound and cone beam CT (2015) (0)
- EP-1208: Primary radiotherapy treatment for patients with multifocal glioma - a case series of 12 patients (2018) (0)
- Immunosuppressive TLI-Based Reconditioning Regimens Enable Engraftment After Graft Rejection or Graft Failure in Patients Treated With Allogeneic Hematopoeitic Stem Cell Transplantation (2007) (0)
- Career Opportunities (2002) (0)
- OC-0280 ReRT with bevacizumab is related to lower rate of radionecrosis as reRT alone for recurrent glioma (2019) (0)
- Importance of sub-cellular localisation of Bcl-2 for the protective effect against erucylphosphocholin-induced apoptosis (2005) (0)
- Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy (2017) (0)
- Treatment Strategies for Follicular Center Cell Non-Hodgkin’s Lymphoma (2010) (0)
- PO-0876: Stereotactic radiosurgery with singleisocenter dynamic arc therapy of multiple brain metastases (2020) (0)
- EP-1522 Radiotherapy with or without antihormonal therapy for PSMA-positive oligorecurrent prostate cancer (2019) (0)
- A new PET-CT score for locally-advanced inoperable NSCLC stage III patients treated with chemoradiotherapy. (2019) (0)
- Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence (2020) (0)
- Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy (2020) (0)
- Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study (2023) (0)
- EP-1521: Optimal trade-off between artefacts and contrast of fiducial markers (2015) (0)
- [Molecular basis of tumor formation. Significance for the diagnosis of malignant diseases]. (1995) (0)
- 156Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node optimized target volume definition (2005) (0)
- Primary radiation therapy in stage I/II indolent orbital lymphoma – a comprehensive retrospective recurrence and toxicity analysis (2022) (0)
- OC-0390 TCGA molecular subclassification is prognostic for LRC of HNSCC after postoperative RCTx (2019) (0)
- PH-0269 Intrafractional monitoring of patients in four immobilization mask systems for cranial radiotherapy (2021) (0)
- 981 poster SURVIVAL PREDICTION BY MIRNA EXPRESSION PATTERNS IN GLIOBLASTOMA (2011) (0)
- Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial (2022) (0)
- OC-0451: Tumour volume, hypoxia and cancer stem cells as prognosticators for LRC after primary RCT in HNSCC (2016) (0)
- Influence of ERK1/ERK2 inhibition on radiation induced apoptosis and cell death in human squamous cell carcinoma cell lines (1999) (0)
- MO-0556 Treating oligometastatic prostate cancer – a survey among the German Society for Radiation Oncology (2022) (0)
- EP-1268 Primary radiation therapy in stage I/II indolent orbital lymphoma: a single-center analysis (2019) (0)
- OC-0344: Risk of second primary cancers after radiotherapy for prostate cancer (2016) (0)
- PO-0886: Leptomeningeal metastases of breast and lung cancer- a retrospective analysis (2020) (0)
- MO-0139 PORT-C improves LRC in a subset of patients with intermediate-risk HNSCC: A matched pair analysis (2022) (0)
- OC-0134 Replacing TG-43U1 by TG-186 in HDR liver brachytherapy has a dosimetric impact on treatment plans (2021) (0)
- Feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion (2016) (0)
- 643 Survival after radical prostatectomy or radiotherapy as primary therapy in patients with nonmetastasized prostate cancer (2015) (0)
- SP-0230 Radiation and TKIs - what is the 2019 evidence? (2019) (0)
- 970 poster RADIOTHERAPY +/− TEMOZOLOMIDE IN ELDERLY PATIENTS WITH GLIOBLASTOMA (2011) (0)
- MA06.08 Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC (2022) (0)
- Stereoscopic X-ray imaging, cone beam CT, and couch positioning in stereotactic radiotherapy of intracranial tumors: preliminary results from a cross-modality pilot installation (2016) (0)
- PO-1421 MR-guided SBRT for primary cardiac sarcomas (2021) (0)
- 18F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy (2022) (0)
- PO-1402 Retrospective analysis of RCT for bladder cancer – Reflection of the real patient cohort (2021) (0)
- Evaluation of displacement of penile bulb induced by probe pressure applied during transperineal ultrasound scan of prostate and its dosimetric consequences (2017) (0)
- [P173] Proposal of a comprehensive pre-treatment QA procedure in IMRT/VMAT techniques (2018) (0)
- OC-0049: Trends in the use of postoperative radiotherapy following mastectomy: a population-based study (2016) (0)
- Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy (2020) (0)
- EP-1372 External Validation of a Survival Score for Limited Disease Small Cell Lung Cancer (LD-SCLC) (2019) (0)
- Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas (2020) (0)
- The ProMotion LMU dataset (2022 edition), prostate intra-fraction motion recorded by transperineal ultrasound (2022) (0)
- 4048 POSTER Distribution of prostate sentinel nodes – a SPECT derived anatomic atlas (2007) (0)
- PO-0929: Mammary chain irradiation: can we reduce the risk of secondary cancer and ischaemic heart disease? (2020) (0)
- 671P Postoperative chemoradiation in combination with cetuximab followed by 6-months cetuximab maintenance in squamous cell carcinoma of the head and neck with high risk of locoregional recurrence (2022) (0)
- Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis (2019) (0)
- PO-1081 Effectiveness and tolerability of radiotherapy for patients with diffuse large cell B-cell lymphoma (2021) (0)
- Wilke H, et al.: Phase II study with folinic acid, etoposide, 5-fluorouracil and cisplatin (FLEP) for advanced gastric cancer. Onkologie 1994;17:154-157 (this issue) (1994) (0)
- O6 Sentinel node based individualization of pelvic IMRT for high risk prostate cancer (2013) (0)
- Geographical distribution of PET/CT detected lymph node metastases in prostate cancer patients compared to the RTOG consensus CTV for elective pelvis irradiation (2014) (0)
- PUB040 Treatment Response and Prophylactic Cranial Irradiation Are Important Prognostic Factors in LD SCLC Patients Staged with cMRI (2017) (0)
- PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives (2018) (0)
- EP-1374 ECOG-PS and its changes in inoperable stage III NSCLC patients treated with chemoradiotherapy (2019) (0)
- 115P Concurrent versus sequential immune checkpoint inhibition in stage III NSCLC patients treated with chemoradiation (2022) (0)
- Current status and recent advances in resection cavity irradiation of brain metastases (2021) (0)
- Dihydroartemisinin-induced apoptosis depends on the presence of proapoptotic Bax or Bak and increases efficacy of ionizing radiation and targeted chemotherapy in vitro (2008) (0)
- Serial TSPO and FET PET monitoring in experimental orthotopic glioblastoma and the impact of inflammation and astrogliosis related to the inoculation process (2022) (0)
- MR-guidance in clinical reality: current treatment challenges and future perspectives (2019) (0)
- OC-0256 Biomarker development from joint analyses of HNSCC xenografts and patients treated by PORT-C (2022) (0)
- Postoperative radiotherapy in pT3a R1-resected prostate cancer patients (2016) (0)
- A Methylome Classifier Identifies Patients at Risk for Locoregional Recurrence after Adjuvant Radiochemotherapy in HPV-DNA negative HNSCC: a Multicenter Trial of the German Cancer Consortium- Radiation Oncology Group (DKTK-ROG) (2019) (0)
- PD-0227 reconstructing the dosimetric impact of intra-fractional prostate motion in MR-guided radiotherapy (2022) (0)
- External validation of a survival score for limited stage small cell lung cancer treated with chemoradiotherapy. (2019) (0)
- 419 Individual risk for biochemical recurrence in localized prostate cancer with positive surgical margins: A multicentre study (2014) (0)
- Correction: MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF (2021) (0)
- OC-0638 Integrated radiogenomics analyses for outcome prognosis in patients with locally advanced HNSCC (2021) (0)
- Dose-Dependent Uptake of 3′-deoxy-3′-[18 F]Fluorothymidine by the Bowel after Total-Body Irradiation (2014) (0)
- An analysis of PSMA-PET/CT-positive lymph node distribution and their coverage by different elective nodal radiation volumes in postoperative prostate cancer patients. (2023) (0)
- PD-0903 Gel dosimetry-based range evaluation as quality assurance tool for adaptive proton radiotherapy (2021) (0)
- Progressive resistance training in cachectic head and neck cancer patients undergoing radiotherapy: a randomized controlled pilot feasibility trial (2018) (0)
- 335 POSTER Irradiation-induced side-effects in the lung: establishment of a murine model for analysis of physiological and histological alterations (2007) (0)
- [Radiation therapy of locally advanced prostate cancer]. (2017) (0)
- Dynamic changes of lymphocyte subsets during multimodal treatment of patients with inoperable stage III NSCLC. (2020) (0)
- PO-0638: FET PET prior to primary RT of glioblastoma patients - a recurrence pattern analysis (2017) (0)
- [Immunotherapy in head and neck squamous cell carcinoma : Abscopal effects in combination with radiotherapy, extraordinary responses in combination with chemotherapy, and pseudoprogression]. (2020) (0)
- Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis (2020) (0)
- The combined effect of membrane operative apoptosis modulator and radiation therapy is dependent form mitochondrial cell death path. (2008) (0)
- Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy. (2023) (0)
- PH-0237: Radiotherapy-induced mesenchymal gene signatures attenuated by VEGF-A blockade in mouse glioblastoma (2020) (0)
- The role of patient performance status and its changes before and after completion of multimodal treatment for inoperable stage III NSCLC. (2019) (0)
- Timing of tumor-induced atelectasis resolution and pulmonary function restoration in the course of image-guided moderate hypofractionated thoracic irradiation: a case report and mini-review of literature (2021) (0)
- EP-1538 IMPACT OF MLC PROPERTIES AND IMRT TECHNIQUES TO THE PLAN QUALITY – PROSTATE WITH AND WITHOUT PELVIC LYMPH NODES (2012) (0)
- Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab (2022) (0)
- DIBH radiotherapy in left-sided breast cancer patients using an optical surface scanning system (2017) (0)
- EP-1159 Normal tissue complication models for acute esophagitis in patients treated with accelerated radiotherapy (2015) (0)
- 889Analysis of complex PKB/AKT signalling pathways in human prostate cancer samples (2005) (0)
- MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC) (2022) (0)
- Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study (2022) (0)
- EP-1243 Bevacizumab as treatment option for cerebral radiation necrosis A case series of 22 patients (2019) (0)
- Contents Vol. 81, 2011 (2012) (0)
- PO-1186: Impact of a low FODMAP diet on rectal gas and rectal volume during radiotherapy of prostate cancer (2020) (0)
- 205 Erucylphosphocholine: molecular requirements for apoptosis induction by a membrane targeted drug (2004) (0)
- 85P Real-world analysis of treatment patterns and efficacy of durvalumab maintenance after chemoradiotherapy in NSCLC patients (2021) (0)
- PD-0800 Radiotherapy in IDH wild-type multifocal high-grade glioma (2021) (0)
- PO-1062: Radiosensitization of tumor cells by Paclitaxel relies on chromosome missegregation and depends on TPX2 (2015) (0)
- SU-F-T-84: Measurement and Monte-Carlo Simulation of Electron Phase Spaces Using a Wide Angle Magnetic Electron Spectrometer. (2016) (0)
- Novel Concepts of Light Application for ALA-PDT of Malignant Gliomas (2010) (0)
- PO-0798: Bevacizumab treatment in recurrent malignant glioma patients – mono-institutional experience in 125 patients (2015) (0)
- PD-0180: Interim Report from the SAVE HEART Study: deep inspiration breath-hold in left-sided breast cancer (2020) (0)
- PO-0940: Porcine-lung-phantom based evaluation of proton dose calculations on 4DCBCT (2018) (0)
- Radiation Oncology reviewer acknowledgment 2012 (2013) (0)
- Updates from the TARGIT A trial for the German centers: Local recurrence and survival (2014) (0)
- Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review (2022) (0)
- OC-0078 Impact of surgery and PET-guided radiotherapy in therapy management of cavernous sinus meningioma (2021) (0)
- 684 Radiotherapy combined with cisplatin, carboplatin, mitomycin C, and 5-FU single drug or two drug chemotherapy compared to radiotherapy alone in unresectable head and neck cancer — a meta-analysis (2003) (0)
- PO-1243: 20 years trend in the paediatric radiooncology: monocentric analysis (2020) (0)
- Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis (2022) (0)
- Current concepts in clinical radiation oncology (2013) (0)
- Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer (2020) (0)
- 78 Modulators of apoptotic signalling (2003) (0)
- Radiation Oncology reviewer acknowledgement 2013 (2014) (0)
- 330 POSTER Dihydroartemisinin induces Bak-dependent mitochondrial apoptosis in tumour cells and increases efficacy of ionizing radiation (2007) (0)
- Subgroups of HPV-positive and HPV-negative head and neck squamous cell carcinoma differing in global copy number changes and prognosis (2017) (0)
- OC-0072: 4D-MRI based evaluation of moving lung tumor target volumes (2017) (0)
- [Preclinical and clinical results in the simultaneous radiochemotherapy of head and neck tumors with Paclitaxel]. (1996) (0)
- 4-miRNA signature combined with MGMT methylation status in glioblastoma: A multicentric retrospective biomarker analysis with accompanying prospective cohort study. (2020) (0)
- Is cetuximab-induced rash conclusion really a remnant of the skin erythema dose? (2013) (0)
- PD-0067 AI auto-segmentation for MRgRT of prostate cancer: evaluating 269 MR images from two institutes (2022) (0)
- Correction to: Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer (2018) (0)
- Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy (2018) (0)
- PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml. (2023) (0)
- OC-0322: 4-miRNA signature and MGMT promoter methylation improve risk stratification in glioblastoma. (2020) (0)
- 308 POSTER Celecoxib-induced apoptosis depends on Bak and is only marginally modified by Bcl-2 overexpression (2007) (0)
- Reply to Chris Parker and Matthew R. Sydes’ Letter to the Editor re: Ute Ganswindt, Arnulf Stenzl, Michael Bamberg and Claus Belka. Adjuvant Radiotherapy for Patients with Locally Advanced Prostate Cancer—A New Standard? Eur Urol 2008;54:528–42 (2009) (0)
- EP-1356: Postoperative radiotherapy in pT3a R1-resected prostate cancer patients (2016) (0)
- PH-0659 Metastasis-free survival after salvage radiotherapy in post-operative prostate cancer patients in the PSMA PET/CT era – a bi-institutional, retrospective analysis (2021) (0)
- 992 poster TREATMENT PARAMETERS INCLUDING EUD FOR RE-RT OF MALIGNANT GLIOMA (2011) (0)
- Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer (2021) (0)
- Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer (2020) (0)
- Adjuvant Therapy for Elderly Breast Cancer Patients after Breast-Conserving Surgery: Outcomes in Real World Practice (2023) (0)
- Radiation Oncology reviewer acknowledgement 2014 (2013) (0)
- OC-0085 Correcting CBCT images for dose calculation using a U-shaped deep convolutional neural network (2019) (0)
- Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment (2016) (0)
- Feasibility of 6 months of maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck (HNC). (2012) (0)
- Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck (2015) (0)
- OC-0113 Evaluation of early clinical response of CT-guided HDR interstitial brachytherapy in HCC (2021) (0)
- Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy (2020) (0)
- 7.P.22 RETROSPECTIVE ANALYSIS OF SIMULTANEOUS RADIOCHEMOTHERAPY WITH SINGLE-AGENT IFOSFAMIDE IN PATIENTS WITH MACROSCOPIC SOFT TISSUE SARCOMA (2010) (0)
- Activation of caspase-8 by ionizing radiation is associated with high radiation sensitivity (1999) (0)
- Comparison of accelerated radiotherapy with conventionally fractionated radiotherapy (Group 2) (2011) (0)
- 616 Fanconi anemia, complementation group A (FancA) overexpression confers radioresistance to oral keratinocytes (2015) (0)
- PD-0398 Accumulated dose comparison of stereotactic MRgRT and proton therapy for central lung tumors (2022) (0)
- PD Video-Assisted Thoracic Surgery ( VATS ) lobectomy for non-small cell lung cancer after induction chemotherapy : A propensity score-matched analysis on behalf of the Italian VATS group (2017) (0)
- 140 A model for the dose response of the spinal cord for irradiated length scales between mm and the whole organ (2006) (0)
- OC-0460 Deep learning based time to event analysis with PET, CT and joint PET/CT for H&N cancer prognosis (2022) (0)
- TARGIT-A trial: Updated results for local recurrence and survival for the German centers. (2013) (0)
- PO-0619: Comparison of a nanoString and RNA microarray gene signature predicting LRC after PORT-C in HNSCC (2017) (0)
- OC-0399 Comparison of high-dose interstitial brachytherapy vs. stereotactic treatment in patients with HCC (2019) (0)
- Abstract ID: 85 Investigating the physics of a CBCT projection shading correction based on a prior CT (2017) (0)
- PO-0966: Translation of a certified MR-only synthetic CT solution for prostate from photon to proton therapy (2018) (0)
- PO-1169: Influence of localisation of PSMA-positive oligo-metastases on efficacy of metastasis-directed EBRT (2020) (0)
- Intra-fraction motion of the prostate is not increased by patient couch shifts (2016) (0)
- Influence of erucylphosphocholin on the sensitivity of glioblastoma cell lines opposite radiation-induced apoptosis (2005) (0)
- EP-1977 Intrafraction motion in CNS radiotherapy with an open mask system using an optical surface imaging (2019) (0)
- Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre (2012) (0)
- Visualization, imaging and new preclinical diagnostics in radiation oncology (2014) (0)
- PO-0973: Dimensionality reduction of clonogenic survival data to identify candidates for radiosensitization (2017) (0)
- PD-0596: Maintaining Pareto-optimality from solution navigation to final, segmented VMAT and dMLC treatment plans (2013) (0)
- PO-1195 Residual MTV after chemoradiotherapy ± immune checkpoint inhibition for inoperable stage III NSCLC (2021) (0)
- PO-1127 The STEREOBRAIN trial: a case-control study of SRS vs WBRT in 4-10 brain metastases (2022) (0)
- Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate (2022) (0)
- OC-0569 A framework for variance-based sensitivity analysis of uncertainties in proton therapy (2019) (0)
- PO-1166 Treatment patterns and efficacy of durvalumab maintenance after CRT in real-world NSCLC patients (2021) (0)
- Intrafractional monitoring of patients using four different immobilization mask systems for cranial radiotherapy (2022) (0)
- SP-0523: ACROP: General procedures, SOPs and current status (2016) (0)
- Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas (2021) (0)
- OC-0582: Gene signatures predict loco-regional control after postoperative radiochemotherapy in HNSCC (2016) (0)
- EP-1186: Real-time intrafraction motion in breast radiotherapy using an optical surface scanner (2017) (0)
- PH-0042 Dosimetric impact of auto segmentation on treatment planning in IMRT for prostate patients (2021) (0)
- Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis (2018) (0)
- PD-0435: Brainlab ExacTrac Dynamic – First pre-clinical validation of surface- and X-Ray positioning accuracy (2020) (0)
- Celecoxib-induced apoptosis involves signaling through the Mcl-1/ Noxa axis and can be blocked by overexpression of Bxl-xL but not Bcl-2 (2008) (0)
- PO-1159 Prognostic role of pro-inflammatory cytokines in multimodal treatment of inoperable stage III NSCLC (2021) (0)
- 380 Analysis of complex PKB/Akt signaling pathways in human prostate cancer samples (2004) (0)
- SU-F-J-186: Enabling Adaptive IMPT with CBCT-Based Dose Recalculation for H&N and Prostate Cancer Patients. (2016) (0)
- PO-1252 Treatment patterns and prognosis in inoperable stage III NSCLC treated with concurrent CRT +/- ICI (2022) (0)
- PO-0255 CT-guided high-dose interstitial brachytherapy vs. SBRT in hepatocellular carcinoma (2021) (0)
- The Heterotopic Thoracic Cardiac Xenotransplantation Model (Pig-to-baboon) in Two Different Groups without and with an Additional Myelodepressive Regime (2015) (0)
- SP-0122 Introduction: Guideline pipeline (2021) (0)
- Prognostic value of pre- to posttreatment primary tumor metabolic volume reduction on 18F-FDG-PET/CT in a homogeneous patient cohort with inoperable locally-advanced non-small cell lung cancer treated with definitive chemoradiotherapy (2017) (0)
- Different position of caspase-8 and bid activation within CD95 or radiation-induced apoptotic cascades (1999) (0)
- Induction of Irradiation Induced Pneumonitis Relies on the CD95/ CD95-L System (2005) (0)
- OC-0144: Maximum response and PCI are important prognostic factors in LD SCLC patients staged with cMRI (2016) (0)
- PD-0161 STEREOTACTIC BRACHYTHERAPY WITH TEMPORARY IODINE-125 SEEDS IN PATIENTS WITH WHO GRADE II GLIOMA (2012) (0)
- EP-1703: Rapid prototyping phantom using LEGO® for MRI distortion correction in MR guided radiation therapy (2017) (0)
- PH-0359: Blood plasma based risk stratification of glioblastoma patients (2020) (0)
- OC-0570: Validating gene signatures in locally advanced HNSCC patients treated by PORT-C and in xenografts (2020) (0)
- X-change symposium: status and future of modern radiation oncology—from technology to biology (2021) (0)
- EP-1446: Stereotactic Body Radiotherapy (SBRT) in patients with HCC in a multimodal treatment setting (2018) (0)
- EP-1673: Hippocampal-sparing radiotherapy for glioblastoma patients using the VMAT technique (2016) (0)
- PH-0485: Clinical evaluation of a deep network organ segmentation algorithm for radiation treatment planning (2020) (0)
- Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer (2021) (0)
- Radiation Oncology reviewer acknowledgement 2014 (2015) (0)
- EP-1076: Recurrence pattern analysis after re-radio-immunotherapy in recurrent malignant glioma patients (2014) (0)
- OC-0321: Transcriptional subtypes in primary and recurrent head and neck squamous cell carcinomas (2020) (0)
- Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study. (2023) (0)
- Hypofractionated radiotherapy for prostate cancer (2014) (0)
- PO-1526 Targeted RT study: preliminary results on acute toxicity of targeted therapies and radiotherapy (2021) (0)
- Comparison of perioperative chemotherapy and neoadjuvant chemoradiation in patients with adenocarcinoma of the gastro-esophageal junction: a population-based evaluation of the Munich Cancer Registry (2017) (0)
- P03.03.A STEREOBRAIN: Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4-10 brain metastases - a non-randomized controlled trial (2022) (0)
- EP-1551: Outcome after PSMA PET based RT in patients with biochemical recurrence or persistence after surgery (2018) (0)
- PD-0066: A 24-miRNA signature predicting HPV status in head and neck cancer (2020) (0)
- Impact of CD 63-positive inflammatory cells on the survival of glioblastoma multiforme patients (2010) (0)
- Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches (2019) (0)
- OC-0163 Risk classification for PSA relapse after PSMAPET-guided RT for oligorecurrent prostate cancer (2019) (0)
- Multimodal "synergistic" treatment based on tumour immunological contexture for advanced non-driver non-small cell lung cancer: A myth or reality? (2020) (0)
- EP-1330: Individual risk for biochemical recurrence in T2/T3a R1 prostate cancer - a multicenter study (2014) (0)
- EP-1923: Regular assessment of isocentre and positioning accuracy in image guided stereotactic radiotherapy (2016) (0)
- OC-0247: The novel HSP90 inhibitor NW457 sensitizes colorectal cancer cells for an immunogenic form cell death (2014) (0)
- Does SBRT improve quality of life in advanced pancreatic ductal adenocarcinoma – A systematic review (2021) (0)
- Characteristics of gated treatment using an optical surface imaging and gating system on an Elekta linac (2015) (0)
- Functional and structural immunodefects after limited volume radiotherapy (1997) (0)
- Membrane-effective apoptosis modulators improve the radiation effect on cell lines of malignant gliomas in vitro: Influence on cell death- and survival signal paths (2006) (0)
- PO-0861 Analysis of nodal and prostatic bed RT in oligorecurrent PC patients treated with PSMA-PETguided RT (2019) (0)
- PD-0529: A method to derive prognostic miRNA patterns predicting the outcome of GBM patients - problems and pitfalls (2013) (0)
- 369 Dihydroartemisinin is a hypoxia active anticancer drug (2010) (0)
- A Privacy-Preserving Log-Rank Test for the Kaplan-Meier Estimator With Secure Multiparty Computation: Algorithm Development and Validation (Preprint) (2020) (0)
- PD-0528: An update on re-irradiation and bevacizumab in recurrent highgrade glioma (2013) (0)
- Prognostic value of dynamic FET-PET in re-irradiation in recurrent malignant glioma (2012) (0)
- EP-2005 A novel method for rectal wall dose accumulation for prostate cancer patients (2019) (0)
- Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1–3 cerebral metastases (2014) (0)
- Pattern and extent of nodal relapse diagnosed with PSMA PET/CT in patients with biochemical failure or persistence after radical prostatectomy (2017) (0)
- EP-1832: Improved 4DCT quality using true phase based triggers (2016) (0)
- Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment. (2023) (0)
- Radiation Oncology reviewer acknowledgement 2015 (2016) (0)
- Techniques of Pelvic Irradiation (2014) (0)
- PO-0933 Single isocenter SRS for multiple brain metastases: dosimetric comparison of DCAT and VMAT (2019) (0)
- Salvage therapies for PSMA PET-positive nodal recurrent prostate cancer (2020) (0)
- PO-0650: Prognostic value of minimal time to peak in dynamic 18F-FET-PET for high-grade glioma re-irradiation (2016) (0)
- Chemoradiation for anal cancer - performance status and achievement of locoregional control predict survival (2017) (0)
- EP-1331: Role of postoperative radiotherapy in DCIS: an observational study of 1,048 cases (2018) (0)
- Multifocal high-grade glioma radiotherapy safety and efficacy (2021) (0)
- PO-1031: Initial report on feasibility of Hypo-IGRT in stage IIB-III NSCLC pts with poor PS & lung function (2020) (0)
- 307 POSTER Inducing apoptosis in colorectal tumor cells through inhibition of Aurora B kinase (2007) (0)
- [OA031] Imaging dose assessment for image guided radiotherapy using a state of the art large-bore CT (2018) (0)
- P3.01-25 Feasibility of Moderate Hypofractionated Thoracic Irradiation for Non-Small Cell Lung Cancer Patients with Very Limited Lung Function (2018) (0)
- EP-1477: Relationship of gamma index evaluation and dose-volume-histograms in patient individual IMRT quality assurance (2014) (0)
- PO-1752 Intrafractional motion detection for spine SBRT via X-ray imaging using ExacTrac Dynamic (2021) (0)
- EP-2295: HNSCC derived cell lines and subclones differ in genomic copy number changes and radiation response (2018) (0)
- OC-0324: Immune contexture in SCCHN and outcome after chemoradiotherapy in an uni- and multicentric cohort (2018) (0)
- Prognostic value of 18F-GE-180 PET in newly diagnosed IDH-wildtype glioma prior to radiotherapy (2020) (0)
- PD-0781 Validation of optical surface/thermal imaging and X-ray positioning accuracy for SRS treatments (2021) (0)
- SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine (2020) (0)
- OC-0043 LSTM networks for real-time respiratory motion prediction for a 0.35 T MR-linac (2022) (0)
- 6001 ORAL Immunosuppressive TLI-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoeitic stem cell transplantation (2007) (0)
- Patient-specific transfer learning for auto-segmentation in adaptive 0.35 T MRgRT of prostate cancer: A bi-centric evaluation. (2022) (0)
- Differential role of residual metabolic tumor volume in patients with inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition. (2021) (0)
- Merging proton radiographies with treatment planning CT for adaptive radiation therapy (2016) (0)
- OC-0482: Paclitaxel at lower nanomolar concentrations sensitizes tumor cells to irradiation by inducing aneuploidy (2014) (0)
- Frequency and Prognostic Relevance of Volumetric MRI Changes in Contrast- and Non-Contrast-Enhancing Tumor Compartments between Surgery and Radiotherapy of IDHwt Glioblastoma (2023) (0)
- Heterogeneity score in inoperable stage III non-small cell lung cancer patients treated with definitive chemoradiotherapy: A single centre analysis. (2019) (0)
- Correction: A deep image-to-image network organ segmentation algorithm for radiation treatment planning: principles and evaluation (2022) (0)
- MP51-17 IS EVERY PT3A-PROSTATE CANCER (PCA) WITH POSITIVE SURGICAL MARGIN A CANDIDATE FOR ADJUVANT RADIATION (ARTX)? INDIVIDUAL RISK ASSESSMENT BASED ON A PATHOLOGICAL GLEASON SCORE PREDICTIVE MODEL – A MULTICENTRE STUDY (2014) (0)
- Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy (2022) (0)
- Preface [ Hot Topic: Radiation Oncology as Mainstay of Modern Cancer Medicine (Guest Editors: Claus Belka & Verena Jendrossek)] (2003) (0)
- PH-0598 Variance-based sensitivity analysis of inter-observer, range and setup variability in proton therapy (2021) (0)
- OC-0513 Cone-beam CT intensity correction using a generative adversarial network and unpaired training (2019) (0)
- SP-0535: Reirradiation for recurrent glioma/GBM: Advances in our knowledge of normal tissue tolerance (2013) (0)
- PV-0143 High-dose CT-guided interstitial brachytherapy of liver metastases in oligometastatic patients (2019) (0)
- Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia (2022) (0)
- Recent advances of PET imaging in clinical radiation oncology (2020) (0)
- Applications of a patient-specific whole-body CT-mesh hybrid computational phantom in second cancer risk prediction (2022) (0)
- Multimodal therapy of cavernous sinus meningioma: Impact of surgery and 68Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcome (2021) (0)
- [I093] Mr-guided radiotherapy at the LMU in Munich: Preliminary studies (2018) (0)
- PO-1311 MR-guided SBRT boost for patients with recurrent gynecological cancers ineligible for brachytherapy (2021) (0)
- SP-0101: A radiation systems biology view of radiation sensitivity of normal and tumour cells (2016) (0)
- PO-0913: Effectiveness of radiotherapy for patients with indolent non-Hodgkin's lymphoma (2020) (0)
- EP-1083 ADJUVANT RADIOCHEMOTHERAPY IN CHOLANGIOCARCINOMA MAY IMPROVE OVERALL SURVIVAL AFTER SURGERY (2012) (0)
- OC-0526 Deep learning based time-to-event prediction for a large multicentric cohort of H&N cancer patients (2021) (0)
- The ProMotion LMU dataset, prostate intra-fraction motion recorded by transperineal ultrasound (2019) (0)
- Interference between tumor mutational burden, HPV status, immune signatures and outcome in patients with head and neck cancer treated with chemoradiotherapy: Results from a multicenter retrospective study of the German Cancer Consortium Radiation Oncology (2018) (0)
- Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients (2022) (0)
- Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks (2020) (0)
- Role of Bcl-2 subcellular localization for radiation-induced apoptosis (2001) (0)
- PO-0976 Adjuvant (chemo)radiotherapy in HNSCC patients: Outcome prediction with comorbidity risk scores (2021) (0)
- PO-1159 Stereotactic radiosurgery and combined immunotherapy with ipilimumab and nivolumab for melanoma brain metastases (2022) (0)
- Pattern of first-site failure and salvage treatment in patients with inoperable stage III non-small cell lung cancer after chemoradiotherapy. (2019) (0)
- EP-1336: The role of adjuvant radiotherapy in male breast cancer patients in clinical practice (2018) (0)
- Stability and reproducibility of 6013 deep inspiration breath-holds in left-sided breast cancer (2020) (0)
- Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: the PUMA trial (2023) (0)
- Molecular imaging after external irradiation: A multiparametric approach for the assessment of radiation effects (2013) (0)
- Prognostic value of CD8-positive tumor stroma-infiltrating lymphocytes and PD-L1 positive tumor cells at initial biopsy in patients with locally advanced NSCLC treated with chemoradiotherapy. (2019) (0)
- Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease (2018) (0)
- The Heterotopic Thoracic Cardiac Xenotransplantation Model (Pig-to-Baboon): Results With and Without a Myelodepressive Protocol (2015) (0)
- PO-0780 Prognostic value of PD-L1 expression in locally advanced NSCLC treated with chemoradiotherapy (2019) (0)
- ANALYSIS OF THE RELATIONSHIP OF P53 STATUS AND RESISTANCE TO CHEMOTHERAPY IN CANCER CELL LINES AS EVALUATED BY LUMINOMETRIC IMMUNOASSAY (LIA) (1998) (0)
- Radiation Oncology reviewer acknowledgement 2015 (2016) (0)
- OC-0417: Random breathing states sampling in a 4D MC dose calculation framework to quantify interplay effects (2018) (0)
- Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy. (2023) (0)
- Novel rotatable tabletop for total-body irradiation using a linac-based VMAT technique (2019) (0)
- Combined treatment with membrane targeted apoptosis modulators and ionising radiation increases apoptotic signaling at the mitochondria (2008) (0)
- Five years after PACIFIC: update on multimodal treatment efficacy based on real-world reports (2023) (0)
- A Novel EPID-Based 3D Dose Reconstruction for IMRT QA (2017) (0)
- EP-1291 FRACTIONATED IMRT-IGRT AS RE-TREATMENT OPTION FOR LOCAL RELAPSE AFTER RADIOSURGERY FOR MENINGIOMA (2012) (0)
- Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis (2017) (0)
- PO-0998: Durvalumab treatment after CRT in inoperable stage III NSCLC – a German radiation oncology survey (2020) (0)
- EP-1007 RADIOTHERAPY AFTER BREAST CONSERVING SURGERY IN AN UNSELECTED COHORT OF 2394 PATIENTS (2012) (0)
- Radiotherapy Versus Chemoradiation in Elderly Head-and-Neck Squamous Cell Carcinoma Patients – A Retrospective International Multicenter Study (2022) (0)
- Scatter correction of 4D cone beam computed tomography to detect dosimetric effects due to anatomical changes in proton therapy for lung cancer. (2023) (0)
- Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer – a prospective pilot study (2020) (0)
- Impact of the primary tumor metabolic volume (PT‐MV) changes in the course of multimodality treatment on overall survival in patients with locally‐advanced non‐small cell lung cancer: 123P (2016) (0)
- EP-1515 Substantial impact of 68Ga-PSMA-PET/CT on the radiotherapeutic approach for prostate cancer (2019) (0)
- Erratum: "ScatterNet: A convolutional neural network for cone-beam CT intensity correction" [Med. Phys. 45, 4916-4926 (2018)]. (2019) (0)
- Hypoxia Methylome Classifier (HDMC) Outperforms Gene Signatures in Identifying HPV-Negative HNSCC Patients at Risk for Locoregional Failure Post Primary Radiochemotherapy: A German Cancer Consortium Radiation Oncology Group (DKTK-ROG) Multicenter Trial (2020) (0)
- Taxane induced apoptosis occurs independently of AP-1 and acidic sphingomyelinase activation (1999) (0)
- EP-1979 Intrafraction stability of 8526 deep inspiration breath holds in left-sided breast cancer (2019) (0)
- 134 Induction of radiation-induced pneumonitis relies on the CD95/CD95-L system (2006) (0)
- 69PD RESPONSE OF PRIMARY THORACIC DISEASE TO CHEMORADIOTHERAPY CORRELATES WITH BRAIN-METASTASIS FREE SURVIVAL IN LIMITED-DISEASE SMALL-CELL LUNG CANCER PATIENTS WITH POOR INITIAL PERFORMANCE STATUS WHO SUCCESSFULLY COMPLETED MULTIMODALITY TREATMENT (2011) (0)
- PO-1512: VMAT based TBI using a novel rotatable tabletop (2020) (0)
- 57P Prognostic role of lung immune scores for prediction of survival in limited-stage small cell lung cancer (2021) (0)
- PII S0360-3016(01)01450-X NCI RADIATION RESEARCH PROGRAM MEETING REPORT (2001) (0)
- PO-1824 Regression and deep learning for transcriptome-based HPV-status prediction in head and neck cancer (2022) (0)
- Radiation Oncology reviewer acknowledgement 2013 (2014) (0)
- OC-0441: Genomic amplification of FancA in HNSCC: mechanisms of radioresistance and clinical relevance (2016) (0)
- PO-1540: Radiomic models for validation in patients with locally advanced HNSCC treated with primary RTCx (2020) (0)
- OC-0440: Impact of chemokine receptor CXCR4 and its ligand SDF1 expression on loco-regional control in HNSCC (2016) (0)
- Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review (2020) (0)
- High-Grade Glioma Radiation Therapy and Reirradiation Treatment Planning Using Translocator Protein Positron Emission Tomography With 18F-GE-180 (2023) (0)
- PO-0997: Evaluation of outcome and toxicity of Durvalumab treatment after CRT in inoperable stage III NSCLC (2020) (0)
- Phagocytic Clearance Apoptotic Cells and Promotes Their Serum-Derived Plasminogen Is Activated by (2012) (0)
- PO-1763 Comparison of intrafractional optical surface/thermal and X-ray imaging for cranial radiotherapy (2021) (0)
- Tumor DNA‐methylome derived epigenetic fingerprint identifies HPV‐negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy (2021) (0)
- Apoptosis signaling as a target for modulation of radiation response (2005) (0)
- The role of FAS-FAS-ligand(FAS-L) interaction for radiation induced apoptosis in human lymphoma cells (1997) (0)
- SP-0544 IMRT: THE POTENTIAL USE AND BENEFIT OF DOSE ESCALATION (2012) (0)
- OC-0276: Combining different genomic signatures to improve the prognostic power for LRC after PORT-C in HNSCC (2018) (0)
- Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy (2020) (0)
- Difference of survival comparing altered fractionated radiotherapy with altered fractionated radioth (2011) (0)
- 231: Clinical Outcome after Multicenter, Open-Label Phase II Trial on Post-Surgery Chemoradiation in Combination with Cetuximab in Squamous Cell Carcinoma of the Head and Neck with High-Risk of Locoregional Recurrence (2016) (0)
- 364 POSTER Importance of the pro-apoptotic Bcl-2-like protein Bak for radiation- and hypoxia-induced apoptosis (2007) (0)
- Erucylphosphocholine increases sensitivity of glioblastoma cell lines to the cytotoxic effects of ionizing radiation (2005) (0)
- OC-0515: Cluster Analysis to Calculate Quality Indices for Different Treatments of Multiple Brain Metastases (2018) (0)
- EP-1188: DIBH radiotherapy in left-sided breast cancer patients using an optical surface scanning system (2017) (0)
- P2.17-18 A Prognostic Score for Patients Receiving Multimodal Treatment for Locally-Advanced Non-Small Cell Lung Cancer (2018) (0)
- Statistical breathing curve sampling to quantify interplay effects of moving lung tumors in a 4D Monte Carlo dose calculation framework. (2022) (0)
- Radiotherapy plus Heat Shock Protein 90 Inhibition: Sensitizing Cancer Cells to Irradiation-Induced Cell Death and Enhancing their Immunogenicity (2017) (0)
- Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma (2020) (0)
- EP-1323: Role of 68Ga-PSMA PET/CT in radiotherapy for prostate cancer: A single centre experience (2017) (0)
- 322 POSTER Molecular determinants of radiation response modulation by TNF-related apoptosis inducing ligand (TRAIL): Role of the pro-apoptotic Bcl-2 protein Bak (2007) (0)
- OC-0220: Exploiting novel combined-modality approaches for treatment of highly aggressive pancreas carcinomas (2017) (0)
- Impact of tumour hypoxia and cancer stem cells on loco-regional control after primary radiochemotherapy in locally advanced HNSCC - results of a multicentre biomarker study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) (2016) (0)
- DeepClassPathway: Molecular pathway aware classification using explainable deep learning. (2022) (0)
- 4024 POSTER IMRT for high risk prostate cancer based on sentinel node optimised target volume definition – first clinical results (2007) (0)
- 86P Prophylactic cranial irradiation in SCLC: A survey of German radiation oncology institutions on recommendations for brain imaging (2018) (0)
- Cetuximab in combination with platinum-based chemotherapy or radiotherapy in patients with recurrent and/or metastatic SSCHN in clinical routine: Updated interim results of the prospective SOCCER study. (2018) (0)
- Radiotherapy in Elderly Breast Cancer Patients (2020) (0)
- EP-1792: Pre-fraction shift and intra-fraction drift of the prostate due to perineal ultrasound probe pressure (2016) (0)
- EP-1222: Intrafraction motion in CNS and HNC radiotherapy: 399 fractions using an optical surface scanner (2018) (0)
- Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study. (2023) (0)
- MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Claus Belka?
Claus Belka is affiliated with the following schools:
